Bibliography

Publication

Kawata NYS, Nishitani S^*, Yao A, Takiguchi S, Mizuno Y, Mizushima S, Makita K, Hamamura S, Saito DN, Okazawa H, Fujisawa TX, Tomoda A^*.
Brain structures and functional connectivity in neglected children with no other types of maltreatment.Brain structures and functional connectivity in neglected children with no other types of maltreatment.
Neuroimage 2024; Mar 7;14(1):5671. (Pre-print). doi: 10.1016/j.neuroimage.2024.120589
Kurata S, Nishitani S^*, Kawata NYS, Yao A, Fujisawa TX, Okazawa H, Tomoda A.
Diffusion tensor imaging of white-matter structural features of maltreating mothers and their associations with intergenerational chain of childhood abuse.
Sci Rep. 2024; Mar 7; 14(1): 5671. (Open Access). doi: 10.1038/s41598-024-53666-0
Cheong Y, Lee S, Okazawa H, Kosaka H, Jung M^*.
Effects of functional polymorphisms of opioid receptor mu 1 (OPRM1) and catechol-O-methyltransferase (COMT) on the neural processing of pain.
Psychiatry Clin Neuros. 2024 Feb 25. doi: 10.1111/pcn.13648 (Online ahead of print).
Makino A^*, Kume K, Mori T, Tsujikawa T, Asai T, Okazawa H, Kiyono Y.
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.
Ann Nucl Med. 2024; 38(2): 112-119. (Open Access) doi: 10.1007/s12149-023-01877-2
Matsunaka T^*, Goi T^*, Kurebayashi H, Morikawa M, Okazawa H, Tsujikawa T.
[¹⁸F]fluorodeoxyglucose positron emission tomography/magnetic resonance imaging-defined extramural venous invasion predicts distant metastasis and reflects strong tumor invasiveness in rectal cancer.
Oncology 2024; 102(2): 99-106. doi: 10.1159/000533422
Isaji Y, Tsuyoshi H^*, Tsujikawa T, Orisaka M, Okazawa H, Yoshida Y.
Prognostic value of ¹⁸F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging.
Sci Rep. 2023; 13(1): 18864. (Open Access). doi: 10.1038/s41598-023-46261-2.
Araie H, Hosono N^*, Tsujikawa T, Kiyono Y, Okazawa H, Yamauchi T.
Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by ¹⁸F-FLT PET imaging.
Int J Hematol 2023 Nov; 118(5):618-626. (Open Access). doi: 10.1007/s12185-023-03658-z
Yomo M, Tada H, Kitai R, Isozaki M, Higashino Y, Matsuda K,; Yamauchi T, Akazawa A, Kawajri S, Oiwa M, Yamada S, Tsubota T, Watanabe A, Okazawa H, Kiyono Y, Arishma H, Kikuta K^*.
Effect of newly developed scissors-attached micro-forceps on the recipient clamp time and occurrence of anastomotic site infarction after bypass surgery for moyamoya disease.
Front Neurol. 2023; 14:1269400.(Open Access) doi: 10.3389/fneur.2023.1269400
Kitazaki Y, Ikawa M, Hamano T^*, Sasaki H, Yamaguchi T, Enomoto S, Shirafuji N, Hayashi K, Yamamura O, Tsujikawa T, Okazawa H, Kimura H, Nakamoto Y.
Magnetic resonance imaging arterial spin labeling hypoperfusion with diffusion-weighted image hyperintensity is useful for diagnostic imaging of Creutzfeldt-Jakob disease.
Front Neurol. 2023; 14:1242615.(Open Access) doi: 10.3389/fneur.2023.1242615
Yamashita M, Kagitani-Shimono K, Hirano Y, Hamatani S, Nishitani S, Yao A, Kurata S, Kosaka H, Jung M, Yoshida T, Sasaki T, Matsumoto K, Kato Y, Nakanishi M, Tachibana M, Mohri I, Tsuchiya KJ, Tsujikawa T, Okazawa H, Shimizu E, Taniike M, Tomoda A, Mizuno Y^*.
Child Developmental MRI (CDM) Project: Protocol for a multi-centre, cross-sectional study on elucidating the pathophysiology of attention-deficit/hyperactivity disorder and autism spectrum disorder through a multi-dimensional approach.
BMJ Open 2023; 13(6): e070157. (Open Access) doi: 10.1136/bmjopen-2022-070157
Araie H, Hosono N^*, Tasaki T, Tsujikawa T, Okazawa H, Yamauchi T.
Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by ¹⁸F-FLT PET/MRI.
Ann Hematol. 2023; 102(7): 1957-1959. (Open Access) doi: 10.1007/s00277-023-05224-3
Takeuchi K, Isozaki M, Higashino Y, Kosaka N, Kikuta K, Ishida S, Kanamoto M, Takei N, Okazawa H, Kimura H^*.
The Utility of arterial transit time measurement for evaluating hemodynamic perfusion state in patient with chronic cerebrovascular stenosis or occlusive disease: Correlative study between magnetic resonance imaging and ¹⁵O-H₂O positron emission tomography.
Magn Reson Med Sci, 2023; 22(3): 289-300. doi: 10.2463/mrms.mp.2020-0123. (Open Access)
Nogami M^*, Tsujikawa T, Maeda H, Kosaka N, Takahashi M, Kinoshita N, Mori M, Makino A, Kiyono Y, Murakami T, Goi T, Okazawa H.
[¹⁸F]FES PET resolves the diagnostic dilemma of COVID-19 vaccine-associated hypermetabolic lymphadenopathy in ER-positive breast cancer.
Diagnostics 2023; 13(11): 1851. (Open Access) doi: 10.3390/diagnostics13111851
Nishikawa Y, Takahashi N^*, Nishikawa S, Shimamoto Y, Nishimori K, Kobayashi M, Kimura H, Tsujikawa T, Kasuno K, Mori T, Kiyono Y, Okazawa H, Iwano M.
Feasibility of renal blood flow measurement using ⁶⁴Cu-ATSM PET/MRI: A quantitative PET and MRI study.
Diagnostics 2023; 13: 1685. (Open Access) doi: 10.3390/diagnostics13101685
Kita A^*, Okazawa H^*, Sugimoto K, Kosaka N, Kidoya E, Tsujikawa T.
Specific binding ratio estimation of [¹²³I]-FP-CIT SPECT using frontal projection image and machine learning.
Diagnostics 2023; 13(8): 1371. (Open Access) doi: 10.3390/diagnostics13081371
Nakagawa K, Cheong Y, Yu J, Habata K, Kamiya T, Shiotsu D, Omori IM, Okazawa H, Kosaka H, Jung M^*.
Region-based analysis of sensory processing using diffusion tensor imaging.
PlosOne 2023 Apr 10; 18(4): e0284250. (Open Access) doi: 10.1371/journal.pone.0284250
Takata K, Kimura H, Ishida S, Isozaki M, Higashino Y, Kikuta K, Okazawa H, Tsujikawa T^*.
Assessment of arterial transit time and cerebrovascular reactivity in moyamoya disease by simultaneous PET/MRI.
Diagnostics 2023; 13(4): 756. (Open Access) doi: 10.3390/diagnostics13040756
Kitade M, Nakajima H^*, Tsujikawa T, Noriki S, Mori M, Kiyono Y, Okazawa H, Matsumine A.
Evaluation of [¹¹C]PK11195 PET/MRI for spinal cord-related neuropathic pain in patients with cervical spinal disorders.
J Clin Med. 2023; 12(1): 116. (Open Access) doi: 10.3390/jcm12010116
Kitazaki Y, Ikawa M^*, Yamaguchi T, Enomoto S, Shirafuji N, Yamamura O, Tsujikawa T, Okazawa H, Kimura H, Nakamoto Y, Hamano T.
Regional cortical hypoperfusion and atrophy correlated with striatal dopaminergic loss in Parkinson's disease: A study using arterial spin labeling MR perfusion.
Neuroradiol 2023; 65(3): 569-577. (Open Access). doi: 10.1007/s00234-022-03085-7
Cheong Y, Nishitani S, Yu J, Habata K, Kamiya T, Shiotsu D, Omori IM , Okazawa H, Tomoda A, Kosaka H, Jung M^*.
The effects of epigenetic age and its acceleration on surface area, cortical thickness and volume in young adults.
Cereb Cortex. 2022 Dec; 32(24): 5654-5663. doi: 10.1093/cercor/bhac043
Tasaki T, Tsujikawa T, Hosono N^*, Mori T, Makino A, Kiyono Y, Okazawa H, Yamauchi T.
Quantitative assessment of bone marrow activity using ¹⁸F-FLT PET in aplastic anemia and myelodysplastic syndromes.
Clin Nucl Med. 2022; 47: 1048-1055. (Open Access) doi: 10.1097/RLU.0000000000004419.
Yamaguchi T, Ikawa M^*, Enomoto S, Shirafuji N, Yamamura O, Tsujikawa T, Okazawa H, Kimura H, Nakamoto Y, Hamano T.
Arterial spin labeling imaging for the detection of cerebral blood flow asymmetry in patients with corticobasal syndrome.
Neuroradiol 2022; 64(9): 1829-1837. doi: 10.1007/s00234-022-02942-9
Arita K^*, Murakami J, Iwaki N, Hosono N, Tasaki T, Tsujikawa T, Okazawa H, Imi T, Nannya Y, Ogawa S, Nakao S.
An eltrombopag-induced remission of bone marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
Br J Haematol 2022; 198(5): e75-e77. (Online Access). doi:10.1111/bjh.18342
Tsujikawa T^*,Takahashi M, Maeda H, Mori T, Makino A, Kiyono Y, Imamura Y, Goi T, Okazawa H.
Metastatic invasive lobular breast cancer presenting as linitis plastica of the colon: Tumor characterization using [¹⁸F]FES PET/MRI. (Case Report)
J Med Imaging Rad Oncol. 2022; 66: 634-636. doi: 10.1111/1754-9485.13333
Tsujikawa T^*, Makino A, Mori T, Tsuyoshi H, Kiyono Y, Yoshida Y, Okazawa H.
PET Imaging of estrogen receptors for gynecological tumors.
Clin Nucl Med. 2022; 47(7): e481-e488. doi: 10.1097/RLU.0000000000004258
Tsujikawa T^*, Makino A, Oikawa H, Ishida S, Mori T, Kiyono Y, Kimura H, Okazawa H.
Assessing the ADC of bone-marrow on whole-body MR images in relation to the fat-suppression method and fat content.
Magn Reson Med Sci. 2022 Jul; 21(3): 407-413. (Open Access). doi: 10.2463/mrms.mp.2020-0129
Okazawa H^*, Ikawa M, Tsujikawa T, Mori T, Makino A, Kiyono Y, Nakamoto Y, Kosaka H, Yoneda M.
Cerebral oxidative stress in early Alzheimer's disease evaluated by ⁶⁴Cu-ATSM PET/MRI: A preliminary study.
Antioxidants 2022; 11(5): 1022. (Open Access) doi: 10.3390/antiox11051022.
Okazawa H^*.
ER imaging for estrogen-related tumors is bothersome but useful. (Invited Perspective: ¹⁸F-4FMFES and ¹⁸F-FDG PET/CT in ER+ endometrial carcinomas: preliminary report.)
J Nucl Med. 2022; 63(5): 700-701. (2021 Oct 14, Online: jnumed.121.263170) doi: 10.2967/jnumed.121.263170
Saito DN, Fujisawa TX^*, Yanaka HT, Fujii T, Kochiyama T, Makita K, Tomoda A, Okazawa H.
Development of attentional networks during childhood and adolescence: A functional MRI study.
Neuropsychopharmaco Rep. 2022; 42(6): 191-198. (Open Access). doi: 10.1002/npr2.12246
Tsujikawa T^*, Anzai M, Umeda Y, Tsuyoshi H, Kosaka N, Kimura H, Okazawa H.
COVID-19 pneumonia detected by [¹⁸F]FDG PET/MRI: a case with negative antigen test and chest X-ray results. (Case Report)
BJR Case Rep. 2022 Mar 9; 7(6): 20210131. doi: 10.1259/bjrcr.20210131
Makino A, Ueda M, Uematsu Y, Ohora T, Ohtani T, Miyagawa S, Fujibayashi Y, Okazawa H, Tokunaga Y, Kiyono Y.
Development of Low Molecular Weight Ligands for Integrin ѓї_vѓА₃.
Chem Pharm Bull. 2022; 70(4): 293-299. (Open Access) doi: 10.1248/cpb.c21-01085.
Seto S, Tsujikawa T^*, Sawai K, Kurebayashi H, Morikawa M, Okazawa H, Goi T.
Feasibility of [¹⁸F]FDG PET/MRI with early-delayed and extended PET as one-stop imaging for staging and predicting metastasis in rectal cancer.
Oncology 2022; 100(4): 212-220. doi: 10.1159/000522205
Nishitani S^*, Kasaba R, Hiraoka D, Shimada K, Fujisawa TX, Okazawa H, Tomoda A.
Epigenetic clock deceleration and maternal reproductive efforts: Associations with increasing gray matter volume of the precuneus.
Front Genetics. 2022 Mar 01; 803584. doi: 10.3389/fgene.2022.803584
Fujisawa TX^*, Nishitani S, Makita K, Yao A, Takiguchi S, Hamamura S, Shimada S, Okazawa H, Matsuzaki H, Tomoda A.
Association of epigenetic differences screened in a few cases of monozygotic twins discordant for attention-deficit hyperactivity disorder with brain structures.
Front Neurosci. 2022, 21 Jan; 15: 799761.(Open Access) doi: 10.3389/fnins.2021.799761.
Habata K, Cheong Y, Kamiya T, Shiotsu D, Omori I, Okazawa H, Jung M^*, Kosaka H^*.
Relationship between sensory characteristics and cortical thickness/volume in autism spectrum disorders.
Transl Psychiatry. 2021 Dec 6; 11(1): 616. doi: 10.1038/s41398-021-01743-7.
Kita A^*, Okazawa H, Sugimoto K, Kaido R, Kosaka N, Shibutani T, Onoguchi M, Kidoya E, Kimura H.
Acquisition count dependence of the specific binding ratio in ¹²³I-FP-CIT SPECT.
Ann Nucl Med. 2021; 35(12): 1271-1278. doi: 10.1007/s12149-021-01668-7
Igarashi C, Okazawa H^*, Islam M, Tsujikawa T, Higashino T, Isozaki M, Kikuta K.
Differences in hemodynamic alteration between atherosclerotic occlusive lesions and moyamoya disease: A quantitative ¹⁵O-PET study.
Diagnostics 2021; 11(10): 1820 (Open Access). doi: 10.3390/diagnostics11101820
Takahashi M, Maeda H, Tsujikawa T^*, Kono H, Mori T, Kiyono Y, Okazawa H, Noriki S, Imamura Y, Goi T.
¹⁸F-Fluoroestradiol tumor uptake is influenced by structural components in breast cancer.
Clin Nucl Med. 2021; 46: 884-889. doi: 10.1097/RLU.0000000000003835
Makino A^*, Okazawa H, Kiyono Y.
Utilization of antibody allows rapid clearance of nanoparticle probes from blood without the need of probe modifications.
ACS Omega. 2021 Sep. 14; 6(32): 21153-21159.(Open Access) doi: 10.1021/acsomega.1c03076
Okamoto Y^*, Kitada R, Kochiyama T, Miyahara M, Naruse H, Sadato N, Okazawa H, Kosaka H.
Importance of the early visual cortex and the lateral occipito-temporal cortex for the self-hand specific perspective process.
Neuroimage: Reports 2021; 1(4): 100046. (Open Access) doi: 10.1016/j.ynirp.2021.100046
Sato M, Umeda Y^*, Tsujikawa T, Mori T, Morikawa M, Anzai M, Waseda Y, Kadowaki M, Kiyono Y, Okazawa H, Ishizuka T. Predictive value of 3'-deoxy-3'-¹⁸F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer.
J Immunother Cancer, 2021 Jul;9(7): e003079. (Open Access). doi: 10.1136/jitc-2021-003079.
Shiotsu D, Jung M^*, Habata K, Kamiya T, Omori IM, Okazawa H, Kosaka H.
Elucidation of the relationship between sensory processing and white matter using diffusion tensor imaging tractography in young adults.
Sci Rep. 2021 Jun; 11(1): 12088. (Open Access) doi: 10.1038/s41598-021-91569-6.
Yamada S, Tsuyoshi H, Yamamoto M, Tsujikawa T, Kiyono Y, Okazawa H, Yoshida Y^*.
Prognostic value of 16ѓї-[¹⁸F]-fluoro-17ѓА-estradiol positron emission tomography as a predictor of disease outcome in endometrial cancer: A prospective study.
J Nucl Med. 2021; 62(5): 636-642. [Online]. doi: 10.2967/jnumed.120.244319
Tsujikawa T^*, Umeda Y, Itoh H, Sakai T, Iwasaki H, Okazawa H, Ishizuka T, Kimura H.
Radiological perspective of COVID-19 pneumonia: The early features and progressive behaviour on high-resolution CT.
J Med Imaging Rad Oncol. 2021 Apr; 65(2): 208-212. (Open Access) doi: 10.1111/1754-9485.13139
Tsuyoshi H^*, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y.
Diagnostic value of ¹⁸F-FDG PET/MRI for revised 2018 FIGO staging in patients with cervical cancer.
Diagnostics 2021; 11(2): 202. (Open Access) doi: 10.3390/diagnostics11020202.
Matsuda H^*, Ito K, Ishii K, Shimosegawa E, Okazawa H, Mishina M, Mizumura S, Ishii K, Okita K, Shigemoto Y, Kato T, Takenaka A, Kaida H, Hanaoka K, Matsunaga K, Hatazawa J, Ikawa M, Tsujikawa T, Morooka M, Ishibashi K, Kameyama M, Yamao T, Miwa K, Ogawa M, Sato N.
Quantitative evaluation of ¹⁸F-flutemetamol PET in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study.
Front Neurol. 2021 Jan; 11: 578753. (Open Access) doi: 10.3389/fneur.2020.578753
Ikawa M^*, Okazawa H, Yoneda M.
Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders.
Biochim Biophys Acta Gen Subj 2020; 1865(3): 129832. doi: 10.1016/j.bbagen.2020.129832
Okazawa H^*, Ikawa M, Tsujikawa T, Makino A, Mori T, Kiyono Y, Kosaka H.
Noninvasive measurement of [¹¹C]PiB distribution volume using integrated PET/MRI.
Diagnostics 2020; 10 (12): E993. (Open Access) doi: 10.3390/diagnostics10120993.
Kuboshita R, Fujisawa TX, Makita K, Kasaba R, Okazawa H, Tomoda A^*.
Intrinsic brain activity associated with eye gaze during mother-child interaction.
Sci Rep. 2020 Nov 3; 10(1): 18903. (Open Access) doi: 10.1038/s41598-020-76044-y.
Tsuyoshi H^*, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y.
Diagnostic value of ¹⁸F-FDG PET/MRI for staging in patients with endometrial cancer.
Cancer Imaging 2020; 20, 75. (Open Access) doi: 10.1186/s40644-020-00357-4.
Tsuyoshi H^*, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y.
Diagnostic value of [¹⁸F]FDG PET/MRI for staging in patients with ovarian cancer.
EJNMMI Res. 2020; 10(1):117. (Open Access) doi: 10.1186/s13550-020-00712-3.
Ikawa M, Okazawa H^*, Nakamoto Y, Yoneda M.
PET imaging for oxidative stress in neurodegenerative disorders associated with mitochondrial dysfunction.
Antioxidants. 2020; 9(9): E861. (Open Access) doi: 10.3390/antiox9090861.
Kanno M, Tsujikawa T^*, Narita N, Ito Y, Makino A, Imamura Y, Kimura H, Okazawa H, Fujieda S.
Comparison of diagnostic accuracy between [¹⁸F]FDG PET/MRI and contrast-enhanced MRI in T staging for oral tongue cancer.
Ann Nucl Med. 2020; 34(12): 952-959. doi: 10.1007/s12149-020-01526-y.
Fan A^*, An H, Moradi F, Rosenberg J, Ishii Y, Nariai T, Okazawa H, Zaharchuk G.
Quantification of brain oxygen extraction and metabolism with [¹⁵O]-gas PET: A technical review in the era of PET/MRI.
NeuroImage 2020 Oct; 220: 117136. (Online ahead of print ) doi: 10.1016/j.neuroimage.2020.117136.
Tsujikawa T^*, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Rahman M, Yoshida Y, Yamauchi Y, Kimura H, Okazawa H.
Integrated ¹⁸F-FDG PET/MRI demonstrates the iron-related bone-marrow physiology.
Sci Rep. 2020; 10: 13878. (Open Access) doi: 10.1038/s41598-020-70854-w
Rahman MGM, Islam MM, Tsujikawa T, Okazawa H^*.
A novel automatic approach for calculation of the specific binding ratio in [I-123]FP-CIT SPECT.
Diagnostics, 2020; 10(5): E289. (Open Access) doi: 10.3390/diagnostics10050289.
Tsujikawa T^*, Kanno M, Ito Y, Oikawa H, Rahman MGM, Narita N, Fujieda S, Okazawa H.
Zero echo time-based PET/MR attenuation correction in patients with oral cavity cancer: initial experience.
Clin Nucl Med, 2020; 45(7): 501-505. doi: 10.1097/RLU.0000000000003091.
Okamoto Y^*, Kitada R, Kochiyama T, Naruse H, Makita K, Miyahara M, Okazawa H, Kosaka H^*.
Visual body part representation in the lateral occipitotemporal cortex in children/adolescents and adults.
Cereb Cortex Commun., 2020; 1(1): tgaa007. (Open Access) doi: 10.1093/texcom/tgaa007
Umeda Y^*, Morikawa M, Anzai M, Ameshima S, Kadowaki M, Waseda Y, Shigemi H, Tsujikawa T, Kiyono Y, Okazawa H, Ishizuka T.
Predictive value of integrated ¹⁸F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer.
J Immunother Cancer, 2020 Apr; 8(1): e000349 (Open Access) doi: 10.1136/jitc-2019-000349.
Sumiya M, Okamoto Y, Koike T, Tanigawa T, Okazawa H, Kosaka H, Sadato N^*.
Attenuated activation of the anterior rostral medial prefrontal cortex on self-relevant social reward processing in individuals with autism spectrum disorder.
NeuroImage: Clinical 2020; 26: 102249. (Open Access) doi: 10.1016/j.nicl.2020.102249.
Okazawa H^*, Ikawa M, Jung M, Maruyama R, Tsujikawa T, Mori T, Rahman MGM, Makino A, Kiyono Y, Kosaka H.
Multimodal analysis using [¹¹C]PiB-PET/MRI for functional evaluation of patients with AlzheimerЃfs disease.
EJNMMI Res, 2020; 10: 30. (Open Access) doi: 10.1186/s13550-020-00619-z.
Matsuda H^*, Uehara T, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
Full report on survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
Ann Nucl Med. 2020; 34(4): 299-304. doi:10.1007/s12149-020-01439-w
Tsuyoshi H, Tsujikawa T^*, Yamada S, Chino Y, Shinagawa A, Kurokawa T, Okazawa H, Yoshida Y.
FDG PET/MRI with high-resolution DWI characterizes the distinct phenotypes of endometrial cancer.
Clin Radiol. 2020; 75: 209-215. doi:10.1016/j.crad.2019.10.018
Jung M^*, Mody M, Fujioka T, Kimura Y, Okazawa H, Kosaka H^*.
Sex differences in white matter pathways related to language ability.
Front Neurosci. 2019 Aug 28; 13: 898.(Open Access) doi: 10.3389/fnins.2019.00898
Tsujikawa T^*, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Yoshida Y, Yamauchi T, Kimura H, Okazawa H.
Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.
Eur J Radiol. 2019; 118: 223-230. doi: 10.1016/j.ejrad.2019.07.022
Komeda H, Kosaka H, Fujioka T, Jung M, Okazawa H^*.
Do individuals with autism spectrum disorders help other people with autism spectrum disorders?: An investigation of empathy and helping behaviors in adults with ASD.
Front Psychiat. 2019 Jun 4; 10: 376. (Open Access) doi: 10.3389/fpsyt.2019.00376
Yamada S, Tsuyoshi H, Tsujikawa T, Okazawa H, Yoshida Y^*.
Predictive value of 16α-[¹⁸F]-fluoro-17β-estradiol PET as a biomarker of progestin therapy resistance in patients with atypical endometrial hyperplasia and low-grade endometrial cancer.
Clin Nucl Med. 2019; 44(7): 574-575. doi: 10.1097/RLU.0000000000002612.
Umeda Y^*, Tsujikawa T, Anzai M, Morikawa M, Waseda Y, Kadowaki M, Shigemi H, Ameshima S, Okazawa H, Ishizuka T.
The vertebral 3'-deoxy-3'-¹⁸F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer.
Eur Radiol. , 2019; 29(7): 3908-3917. doi: 10.1007/s00330-019-06161-4.
Okazawa H^*, Tsujikawa T, Higashino Y, Kikuta K, Mori T, Makino A, Kiyono Y.
No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction.
EJNMMI Res, 2019 Mar 19; 9(1): 26. (Open Access) doi: 10.1186/s13550-019-0494-9
Tsujikawa T^*, Tasaki T, Hosono N, Mori T, Makino A, Kiyono Y, Zanotti-Fregonara P, Yamauchi T, Okazawa H.
¹⁸F-FLT PET/MRI for bone marrow failure syndrome-initial experience.
EJNMMI Res, 2019 Feb; 9(1): 16. (Open Access) doi: 10.1186/s13550-019-0490-0.
Amemiya K, Morita T, Saito DN, Ban M, Shimada K, Okamoto Y, Kosaka H, Okazawa H, Asada M, Naito E^*.
Local-to-distant development of the cerebrocerebellar sensorimotor network in the typically developing human brain: a functional and diffusion MRI study.
Brain Struct Funct., 2019 Apr; 224(3): 1359-1375. (Open Access) doi: 10.1007/s00429-018-01821-5.
Rahman MGM, Islam MM, Tsujikawa T, Kiyono Y, Okazawa H^*.
Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
Ann Nucl Med. 2019; 33 (1): 14-21. (Open Access) doi: 10.1007/s12149-018-1297-1
Ikawa M^*, Kimura, H, Kitazaki Y, Sugimoto K, Matsunaga A, Hayashi K, Yamamura O, Tsujikawa T, Hamano T, Yoneda M, Okazawa H, Nakamoto Y.
Arterial spin labeling MR imaging for the clinical detection of cerebellar hypoperfusion in patients with spinocerebellar degeneration.
J Neurol Sci. 2018: 394: 58-62. doi: 10.1016/j.jns.2018.09.007
Okazawa H^*, Higashino Y, Tsujikawa T, Arishima H, Mori T, Kiyono Y, Kimura H, Kikuta K.
Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation.
Eur J Radiol 2018; 105: 102-109. doi: 10.1016/j.ejrad.2018.05.033
Okamoto Y^*, Kitada R, Miyahara M, Kochiyama T, Naruse H, Sadato N, Okazawa H, Kosaka H^**.
Altered perspective-dependent brain activation while viewing hands and associated imitation difficulties in individuals with autism spectrum disorder.
Neuroimage Clinical 2018; 19: 384-395. (Open Access) doi: 10.1016/j.nicl.2018.04.030
Tsujikawa T^*, Tsuyoshi H, Kanno M, Yamada S, Kobayashi M, Narita N, Kimura H, Fujieda S, Yoshida Y, Okazawa H.
Selected ¹⁸F-FDG PET radiomic features remain the same.
Oncotarget 2018; 9: 20734-20746. (Open Access) doi: 10.18632/oncotarget.25070
Inui Y^*, Ichihara T, Uno M, Ishiguro M, Ito K, Kato K, Sakuma H, Okazawa H, Toyama H.
CT-based attenuation correction and resolution compensation for I-123 IMP brain SPECT normal database: a multicenter phantom study.
Ann Nucl Med. 2018; 32(5): 311-318. doi: 10.1007/s12149-018-1248-x.
Tsujikawa T^*, Narita N, Kanno M, Takabayashi T, Fujieda S, Okazawa H.
Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.
Ann Nucl Med. 2018; 32(4): 239-249. doi: 10.1007/s12149-018-1244-1.
Makino A^*, Miyazaki A, Tomoike A, Kimura H, Arimitsu K, Hirata M, Ohmomo Y, Nishii R, Okazawa H, Kiyono Y, Ono M, Saji H.
PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Biooran Med Chem 2018; 26(8): 1609-1613. doi: 10.1016/j.bmc.2018.02.007.
Morita T^*, Saito DN, Ban M, Shimada K, Okamoto Y, Kosaka H, Okazawa H, Asada M, Naito E.
Self-face recognition begins to share active region in right inferior parietal lobule with proprioceptive illusion during adolescence.
Cereb Cortex 2018; 28(4):1532-1548. doi: 10.1093/cercor/bhy027.
Tsujikawa T^*, Yamamoto M, Shono K, Yamada S, Tsuyoshi H, Kiyono Y, Kimura H, Okazawa H, Yoshida Y.
Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an ¹⁸F-FDG PET/CT texture analysis.
Ann Nucl Med 2017; 31(10): 752-757. doi: 10.1007/s12149-017-1208-x.
Naito E^*, Morita T, Saito DN, Ban M, Shimada K, Okamoto Y, Kosaka H, Okazawa H, Asada M.
Development of right-hemispheric dominance of inferior parietal lobule in proprioceptive awareness task.
Cereb Cortex 2017; 27(11): 5385-5397. doi: 10.1021/acs.analchem.6b04777
Fukuoka Y, Nakano A, Tama N, Hasegawa K, Ikeda H, Morishita T, Ishida K, Kaseno K, Amaya N, Uzui H, Okazawa H, Tada H.
Impaired myocardial microcirculation in the flow-glucose metabolism mismatch regions in revascularized acute myocardial infarction.
J Nucl Cardiol. 2017; 24(5): 1641-1650. DOI: 10.1007/s12350-016-0526-z
Neishi H, Ikawa M, Okazawa H^*, Tsujikawa T, Arishima H, Kikuta K, Yoneda M.
Precise evaluation of striatal oxidative stress corrected for severity of dopaminergic neuronal degeneration in patients with Parkinson's disease: A study with ⁶²Cu-ATSM PET and ¹²³I-FP-CIT SPECT.
Eur Neurol 2017; 78(3-4): 161-168. doi: 10.1159/000479627
Tsujikawa T^*, Rahman T, Yamamoto M, Yamada S, Tsuyoshi H, Kiyono Y, Kimura H, Yoshida Y, Okazawa H.
¹⁸F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer.
Ann Nucl Med 2017; 31: 678-685. doi: 10.1007/s12149-017-1199-7
Yaku H^*, Yoshida Y, Okazawa H, Kiyono Y, Fujita Y, Miyoshi D.
Highly sensitive telomerase assay insusceptible to telomerase and PCR inhibitors for cervical cancer screening using scraped cells.
Anal Chem 2017; 89(13): 6948-6953. (Open Access) doi: 10.1021/acs.analchem.6b04777
Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H^*.
Estimation of arterial input by a noninvasive image derived method in brain H₂¹⁵O PET study: Confirmation of arterial location using MR angiography.
Phys Med Biol. 2017; 62: 4514-4524. (Open Access) doi: 10.1088/1361-6560/aa6a95.
Chino Y, Tsuyoshi H, Tsujikawa T, Okazawa H, Yoshida Y^*.
A novel diagnostic strategy using 16ѓї-[¹⁸F] fluoro-17-ѓА-estradiol (¹⁸F-FES) PET/MRI to achieve complete resection of intravenous leiomyomatosis in reproductive-age women.
Clin Nucl Med 2017; 42(7): e335-e336. doi: 10.1097/RLU.0000000000001678.
Shimada K, Fujisawa TX, Takiguchi S, Naruse H, Kosaka H, Okazawa H, Tomoda A.
Ethnic differences in COMT genetic effects on striatal grey matter alterations associated with childhood ADHD: A voxel-based morphometry study in a Japanese sample.
World J Biol Psychiatry. 2017; 18(4): 322-328. doi: 10.3109/15622975.2015.1102325.
Morita T, Saito DN, Ban M, Shimada K, Okamoto Y, Kosaka H, Okazawa H, Asada M, Naito E.
Self-face recognition shares brain regions active during proprioceptive illusion in the right inferior fronto-parietal superior longitudinal fasciculus III network.
Neuroscience 2017; 348: 288-301. (Open Access) doi: 10.1016/j.neuroscience.2017.02.031.
Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H^*.
Pixel-by-pixel precise delay correction for measurement of cerebral hemodynamic parameters in H₂¹⁵O PET study.
Ann Nucl Med 2017; 31(4): 283-294. (Open Access) doi: 10.1007/s12149-017-1156-5.
Okamoto Y, Kosaka H, Kitada R, Seki A, Tanabe HC, Hayashi MJ, Kochiyama T, Saito DN, Yanaka HT, Munesue T, Ishitobi M, Omori M, Wada Y, Okazawa H, Koeda T, Sadato N.
Age-dependent atypicalities in body- and face-sensitive activation of the EBA and FFA in individuals with ASD.
Neurosci Res. 2017; 119: 38-52. pii: S0168-0102(16)30243-7. doi: 10.1016/j.neures.2017.02.001.
Yamamoto M, Tsujikawa T, Chino Y, Kurokawa T, Shinagawa A, Mori T, Kiyono Y, Okazawa H, Yoshida Y.
¹⁸F-FDG/¹⁸F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
Oncotarget 2017; 8(14): 22581-22589. (Open Access) doi: 10.18632/oncotarget.15127.
Arakawa K, Ikawa M, Tada H, Okazawa H, Yoneda M.
Mitochondrial cardiomyopathy and usage of L-arginine.
(In)"L-Arginine in Clinical Nutrition"; Patel VB & Preedy VR (eds), Springer, Chapter 36: 461-470. ISBN: 978-3-319-26009-9.
Morita T, Kosaka H, Saito DN, Fujii T, Ishitobi M, Munesue T, Inohara K, Okazawa H, Kakigi R, Sadato N.
Neural correlates of emotion processing during observed self-face recognition in individuals with autism spectrum disorders.
Research in Autism Spectrum Disorders. 2016; 26: 16-32. DOI: 10.1016/j.rasd.2016.02.011
Kosaka H^*, Okamoto Y, Munesue T, Yamasue H, Inohara K, Fujioka T, Anme T, Orisaka M, Ishitobi M, Jung M, Fujisawa T, Tanaka S, Arai S, Asano M, Saito D, Sadato N, Tomoda A, Omori M, Sato M, Okazawa H, Higashida H, Wada Y.
Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: A 24-week randomized clinical trial.
Transl Psychiat. 2016; 6(8): e872. (Open Access) doi: 10.1038/tp.2016.152
Isozaki M, Arai Y, Higashino Y, Okazawa H, Kikuta KI.
Cerebral hyperperfusion syndrome resulting in subarachnoid hemorrhage after carotid artery stenting.
Ann Nucl Med. 2016; 30(9): 669-674. DOI: 10.1007/s12149-016-1108-5
Tsujikawa T, Kimura H^*, Matsuda T, Fujiwara Y, Isozaki M, Kikuta K, Okazawa H.
Arterial transit time mapping obtained by pulsed continuous 3D ASL imaging with multiple post-label delay acquisitions: Comparative study with PET-CBF in patients with chronic occlusive cerebrovascular disease.
PLoS ONE 2016 Jun 8; 11(6): e0156005. (Open Access) DOI: 10.1371/journal.pone.0156005.
Tsujikawa T^*, Asahi S, Oh M, Sato Y, Narita N, Makino A, Kiyono Y, Tsuchida T, Kimura H, Fujieda S, Okazawa H.
Assessment of the tumor redox status in head and neck cancer by ⁶²Cu-ATSM PET.
PLoS ONE 2016 May17; 11(5): e0155635. (Open Access) DOI:10.1371/journal.pone.0155635
Fujioka T, Inohara K, Okamoto Y, Masuya Y, Ishitobi M, Saito DN, Jung M, Arai S, Matsumura Y, Fujisawa TX, Narita K, Suzuki K, Tsuchiya KJ, Mori N, Katayama T, Sato M, Munesue T, Okazawa H, Tomoda A, Wada Y, Kosaka H.
GazefinderR as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults.
Mol Autism. 2016 Mar23; 7: 19. DOI: 10.1186/s13229-016-0083-y.
Yamamoto M, Tsujikawa T, Okazawa H, Yoshida Y.
Impact on PET texture features of imaging biomarkers for predicting survival of patients with uterine sarcoma-preliminary results.
Biomarker J. 2016; 2(1): 13. URL: http://biomarkers.imedpub.com/archive.php
Rahman T, Tsujikawa T^*, Yamamoto M, Chino Y, Shinagawa A, Kurokawa T, Tsuchida T, Kimura H, Yoshida Y, Okazawa H.
Different prognostic implications of ¹⁸F-FDG PET between histological subtypes in patients with cervical cancer.
Medicine (Baltimore). 2016; 95(9): e3017. DOI: 10.1097/MD.0000000000003017.
Yamamoto M, Tsujikawa T, Shinagawa A, Chino Y, Kurokawa T, Kiyono Y, Okazawa H, Yoshida Y.
Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy.
Cancer Sci. 2016; 107(4): 478-485. DOI: 10.1111/cas.12890.
Jung M, Maria M, Saito DN, Tomoda A, Okazawa H, Wada Y, Kosaka H.
Sex differences in the default mode network with autism spectrum traits.
PLoS One 2015; 10(11): e0143126. DOI: 10.1371/journal.pone.0143126.
Umeda Y, Demura Y, Morikawa M, Anzai M, Kadowaki M, Ameshima S, Tsuchida T, Tsujikawa T, Kiyono Y, Okazawa H, Ishizaki T, Ishizuka T.
Prognostic value of dual-time-point [¹⁸F]-2-fluoro-2-deoxyglucose PET for idiopathic pulmonary fibrosis.
J Nucl Med 2015; 56(12): 1869-1875. DOI: 10.2967/jnumed.115.163360.
Wakahara S, Konoshita T, Sakai A, Nakaya T, Ichikawa M, Yamamoto K, Imagawa M, Kimura H, Okazawa H, Ishizuka T.
Intrathoracic benign goiter imaged by ¹⁸F-FDG-PET :A case report.
Medicine 2015; 94(32): e1387. DOI: 10.1097/MD.0000000000001387.
Kobayashi M, Mori T, Tsujikawa T, Ogai K, Sugama J, Kiyono Y, Kawai K, Okazawa H.
Comparison of image quality with ⁶²Cu and ⁶⁴Cu-labeled radiotracers in positron emission tomography whole-body phantom imaging.
Hell J Nucl Med. 2015 May-Aug; 18(2): 103-107. DOI: 10.1967/s002449910203
Shimada K, Takiguchi S, Mizushima S, Fujisawa TX, Saito DN, Kosaka H, Okazawa H, Tomoda A.
Reduced visual cortex grey matter volume in children and adolescents with reactive attachment disorder.
NeuroImage Clin. 2015 Jul; 9: 13-19. DOI: 10.1016/j.nicl.2015.07.001.
Lin C, Kume K, T, Martinez ME, Okazawa H, Kiyono Y.
Predictive value of early stage uptake of 3'-deoxy-3'-¹⁸F-fluorothymidine in cancer cells treated with charged particle irradiation.
J Nucl Med 2015; 56: 945-950. DOI: 10.2967/jnumed.114.152983.
Ikawa M, Okazawa H, Tsujikawa T, Matsunaga A, Yamamura O, Mori T, Hamano T, Kiyono Y, Nakamoto Y, Yoneda M.
Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study.
Neurology 2015; 84(20): 2033-2039. DOI: 10.1212/WNL.0000000000001588.
Tsuji K, Kishi S, Tsuchida T, Yamauchi T, Ikegaya S, Urasaki Y, Fujiwara Y, Ueda T, Okazawa H, Kimura H.
Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
J Magn Reson Imaging. 2015; 41(6): 1601-1607. DOI: 10.1002/jmri.24714
Mitsuya H, Omata N, Kiyono Y, Murata T, Mita K, Okazawa H, Wada Y.
The co-occurrence of zinc deficiency and social isolation has the opposite effects on mood compared with either condition alone due to changes in the central norepinephrine system.
Behav Brain Res. 2015; 284: 125-130. DOI: 10.1016/j.bbr.2015.02.005.
Komeda H, Kosaka H, Saito DN, Mano Y, Jung M, Fujii T, Yanaka HT, Munesue T, Ishitobi M, Sato M, Okazawa H.
Autistic empathy toward autistic others.
Soc Cogn Affect Neurosci. 2015; 10(2): 145-152. DOI: 10.1093/scan/nsu126
Okazawa H, Ikawa M, Tsujikawa T, Kiyono Y, Yoneda M.
Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative disease.
Q J Nucl Med Mol Imaging 2014 Dec; 58(4): 387-397.
Uchida K, Nakajima H, Okazawa H, Kimura H, Yoshida A, Baba H.
Clinical significance of 3D-MRI/¹⁸F-FDG PET fusion imaging of patients with cervical compressive myelopathy.
(In)"Neuroprotection and Regeneration of the Spinal Code.Ѓh; Uchida K, Nakamura M, Ozawa H, Katoh S. (eds), Springer, Tokyo Heidelberg New York Dordrecht London, pp. 367-376, 2014. ISBN: 978-4-431-54501-9 (Print) ISBN: 978-4-431-54502-6 (Online)
Okamoto Y, Kitada R, Tanabe HC, Hayashi MJ , Kochiyama T, Munesue T, Ishitobi M, Saito DN, Yanaka HT, Omori M, Wada Y, Okazawa H, Sasaki AT, Morita T, Itakura S, Kosaka H, Sadato N.
Attenuation of the contingency detection effect in the extrastriate body area in autism spectrum disorder.
Neurosci Res. 2014 Oct; 87: 66-76. DOI: 10.1038/mp.2014.69
Omata N, Mizuno T, Mitsuya H, Mita K, Higashi Y, Kamichika T, Kiyono Y, Okazawa H, Wada Y.
Neuronal plasticity in depressive or manic states - New assessment of our hypothesis: Mania is an extension of depression from the perspective of neuronal plasticity.
Med Hypotheses. 2014 Oct; 83(6): 845-846. DOI: 10.1016/j.mehy.2014.10.004.
Sato Y, Tsujikawa T, Oh M, Mori T, Kiyono Y, Fujieda S, Kimura H, Okazawa H.
Assessing tumor hypoxia in head and neck cancer by PET with ⁶²Cu-diacetyl-bis(N⁴-methylthiosemicarbazone).
Clin Nucl Med. 2014; 39(12): 1027-1032. DOI: 10.1097/RLU.0000000000000537.
Jung M, Kosaka H, Saito DN, Ishitobi M, Morita T, Inohara K, Asano M, Arai S, Munesue T, Tomoda A, Wada Y, Sadato N, Okazawa H, Iidaka T.
Default mode network in young male adults with autism spectrum disorder: relationship with autism spectrum traits.
Mol Autism 2014 Jun 11; 5:35. DOI: 10.1186/2040-2392-5-35.
Oyama N, Ito H, Takahara N, Miwa Y, Akino H, Kudo T, Okazawa H, Fujibayashi Y, Komatsu K, Tsukahara K, Yokoyama O.
Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: Comparison of C-11 acetate and F-18 FDG PET imaging.
Clin Nucl Med. 2014; 39(3): e208-214. doi: 10.1097/RLU.0000000000000287
Muramatsu T, Ikawa M, Yoneda M, Sugimoto K, Matsunaga A, Yamamura O, Hamano T, Okazawa H, Nakamoto Y.
Pathophysiological decrease in the regional cerebral blood flow in HashimotoЃfs encephalopathy: a multiple-case SPECT study.
Eur Neurology.2014; 72(1-2): 13-19. DOI:10.1159/000358220
Fujii T, Saito DN, Yanaka HT, Kosaka H, Okazawa H.
Depressive mood modulates the anterior lateral CA1 and DG/CA3 during a pattern separation task in cognitively intact individuals: A functional MRI study.
Hippocampus. 2014; 24(2): 212-224. DOI: 10.1002/hipo.22216.
Okazawa H, Kim YK.
Cerebrovascular disease and PET.
(In)"Clinical PET and PET/CT: Principles and applications"; Kim EE, Lee MC, Inoue T, Wong WH. (eds), Springer, New York Heidelberg Dordrecht London, 175-185, 2013. ISBN: 978-1-4419-0801-8 (Print) ISBN: 978-1-4419-0802-5 (Online)
Oyama N, Ito H, Aoki Y, Miwa Y, Akino H, Kudo T, Okazawa H, Fujibayashi Y, Welch M, Yokoyama O.
Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mL.
Hell J Nucl Med. 2013 May-Aug; 16(2): 146-147. [http://nuclmed.web.auth.gr/magazine/eng/may13/68.pdf]
Mizuno T, Omata N, Murata T, Mitsuya H, Maruoka N, Mita K, Kiyono Y, Okazawa H, Ikeda H, Wada Y.
Mania: Not the opposite of depression, but an extension? Neuronal plasticity and polarity.
Med Hypotheses. 2013; 81(2): 175-179. DOI: 10.1016/j.mehy.2013.05.012
Komeda H, Kosaka H, Saito DN, Inohara K, Munesue T, Ishitobi M, Sato M, Okazawa H.
Episodic memory retrieval for story characters in high-functioning autism.
Mol Autism 2013; 24; 4(1): 20. DOI: 10.1097/WNR.0b013e32836347b7
Fukuoka Y, Nakano A, Uzui H, Amaya N, Ishida K, Arakawa K, Kudo T, Okazawa H, Ueda T, Lee JD, Tada H.
Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction.
Eur J Nucl Med Mol Img 2013; 40(8):1155-1162. DOI: 10.1007/s00259-013-2423-x
Tsuyoshi H, Morishita F, Orisaka M, Okazawa H, Yoshida Y.
¹⁸F-Fluorothymidine positron emission tomography is a potential predictive imaging biomarker of the response to gemcitabine-based chemotherapeutic treatment for recurrent ovarian cancer: preliminary results in three patients.
Clin Nucl Med 2013; 38(7): 560-563 DOI: 10.1097/RLU.0b013e318292ee9c
Uchida K, Nakajima H, Miyazaki T, Tsuchida T, Hirai T, Sugita D, Watanabe S, Takeura N, Yoshida A, Okazawa H, Baba H.
¹⁸F-FDG PET/CT for diagnosis of osteosclerotic and osteolytic vertebral metastatic lesions: Comparison with bone scintigraphy.
Asian Spine J. 2013: 7(2): 96-103. DOI: 10.4184/asj.2013.7.2.96
Zhao Z, Yoshida Y, Kurokawa T, Kiyono Y, Mori T, Okazawa H.
FES- and FDG-PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: Correlation with immunohistochemical analysis.
J Nucl Med. 2013; 54(4): 499-506. DOI: 10.2967/jnumed.112.113472
Tsuchida T, Morikawa M, Demura Y, Umeda Y, Okazawa H, Kimura H.
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
J Magn Reson Imaging. 2013; 38(1): 80-88. DOI: 10.1002/jmri.23959
Maruoka N, Murata T, Omata N, Mitsuya H, Kiyono Y, Okazawa H, Wada Y.
Region-specific causal mechanism in the effects of ammonia on cerebral glucose metabolism in the rat brain.
J Neural Transm. 2013; 120(3): 375-382 DOI 10.1007/s00702-012-0906-8
Omata N, Murata T, Maruoka N, Ikeda H, Mitsuya H, Mizuno T, Mita K, Asano M, Kiyono Y, Okazawa H, Wada Y.
Effect of dietary zinc deficiency on ischemic vulnerability of the brain.
Neurosci Lett. 2012; 531(1):10-13. DOI:pii: S0304-3940(12)01354-7. 10.1016/j.neulet.2012.10.013.
Kobayashi M, Hashimoto F, Ohe K, Nadamura T, Nishi K, Shikano N, Nishii R, Higashi T, Okazawa H, Kawai K.
Transport mechanism of ¹¹C-labeled L- and D-methionine in human-derived tumor cells.
Nucl Med Biol. 2012; 39(8):1213-1218. DOI: 10.1016/j.nucmedbio.2012.06.006
Uchida K, Nakajima H, Okazawa H, Kimura H, Kudo T, Baba H.
Clinical significance of MRI/¹⁸F-FDG PET fusion imaging of the spinal cord of patients with cervical compressive myelopathy.
Eur J Nucl Med Mol Img 2012; 39(10):1528-1537. DOI: 10.1007/s00259-012-2192-y
Amaya N, Nakano A, Uzui H, Mitsuke Y, Geshi T, Okazawa H, Ueda T, Lee JD.
Relationship between microcirculatory dysfunction and resolution of ST-segment elevation in the early phase after primary angioplasty in patients with ST-segment elevation myocardial infarction.
Int J Cardiol. 2012; 159(2):144-149. DOI: 10.1016/j.ijcard.2011.02.045
Tanabe HC, Kosaka H, Saito DN, Koike T, Hayashi MJ, Izuma K, Komeda H, Ishitobi M, Omori M, Munesue T, Okazawa H, Wada Y, Sadato N.
Hard to "tune in": Neural mechanisms of live face-to-face interaction in individuals with high-functioning autistic spectrum disorder.
Front in Hum Neurosci. 2012; 6(268): 1-15. DOI: 10.3389/fnhum.2012.00268
Yamauchi H, Higashi T, Kagawa S, Nishii R, Kudo T, Sugimoto K, Okazawa H, Fukuyama H.
Is misery perfusion still a predictor of stroke in symptomatic major cerebral artery disease?
Brain 2012; 135(8): 2515-2526. DOI: 10.1093/brain/aws131
Tsujikawa T, Yoshida Y, Maeda H, Tsuchida T, Mori T, Kiyono Y, Kimura H, Okazawa H.
Oestrogen-related tumour phenotype: PET characterisation with ¹⁸F-FDG and ¹⁸F-FES.
Br J Radiol. 2012; 85(1015): 1020-1024. DOI: 10.1259/bjr/26645378
Sarazawa K, Nakano A, Uzui H, Mitsuke Y, Geshi T, Okazawa H, Ueda T, Lee JD.
Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling in patients with reperfused ST-segment elevation myocardial infarction.
J Nucl Cardiol. 2012; 19(3): 507-514. DOI: 10.1007/s12350-012-9525-x
Kiyono Y, Mori T, Okazawa H.
Positron emission tomography radiopharmaceuticals for sex steroid hormone receptor imaging.
Curr Med Chem. 2012 Jul 1; 19(20): 3266-70. DOI: 10.2174/092986712801215919.
Morita T, Kosaka H, Saito DN, Ishitobi M, Munesue T, Itakura S, Omori M, Okazawa H, Wada Y, Sadato N.
Emotional responses associated with self-face processing in individuals with autism spectrum disorders: An fMRI study.
Social Neuroscience. 2012; 7(3): 223-239. DOI: 10.1080/17470919.2011.598945
Ishida K, Geshi T, Nakano A, Uzui H, Mitsuke Y, Okazawa H, Ueda T, Lee JD.
Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction.
Int J Cardiol. 2012; 155(3): 442-447. DOI: 10.1016/j.ijcard.2011.11.015
Yoneda M, Ikawa M, Arakawa K, Kudo T, Kimura H, Fujibayashi Y, Okazawa H.
In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.
Biochim Biophys Acta. 2012; 1820(5): 615-618. DOI: 10.1016/j.bbagen.2011.04.018
Kositwattanarerk A, Oh M, Kudo T, Kiyono Y, Mori T, Kimura Y, Maruyama M, Fujibayashi Y, Fujieda S, Okazawa H.
Different distribution of ⁶²Cu ATSM and ¹⁸F-FDG in head-and-neck cancers.
Clin Nucl Med. 2012; 37(3): 252-257. DOI: 10.1097/RLU.0b013e31823eaadb
Yoshii Y, Yoneda M, Ikawa M, Furukawa T, Kiyono Y, Mori T, Yoshii H, Oyama N, Okazawa H, Saga T, Fujibayashi Y.
Radiolabeled Cu-ATSM as a novel indicator of over-reduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ⁰ cells and cybrids carrying MELAS DNA mutation.
Nucl Med Biol. 2012; 39(2): 177-185. DOI: 10.1016/j.nucmedbio.2010.08.009
Kobayashi M, Mori T, Kiyono Y, Tujikawa T, Maruyama R, Higaki Y, Shikano N, Nishii R, Kawai K, Okazawa H.
Appropriate parameters of ordered-subset expectation maximization algorithm on measurement of myocardial blood flow and oxygen consumption with ¹¹C-acetate PET.
Nucl Med Commun. 2012; 33(2):130-138. DOI: 10.1097/MNM.0b013e32834e7f5c
Nakamura M, Kitagawa Y, Yamazaki Y, Hata H, Kotsuji M, Fujibayashi Y, Okazawa H, Yonekura Y, Sano K.
Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.
Odontology. 2012; 100(1): 87-94. DOI: 10.1093/hmg/ddr539
Kobayashi M, Mori T, Kiyono Y, Tiwari VN, Maruyama R, Kawai K, Okazawa H.
Cerebral oxygen metabolism of rats using injectable ¹⁵O-oxygen with a steady-state method.
J Cereb Blood Flow Metab. 2012: 32(1): 33-40. DOI: 10.1038/jcbfm.2011.125
Ikawa M, Okazawa H, Kudo T, Kuriyama M, Fujibayashi Y, Yoneda M.
Evaluation of striatal oxidative stress in patients with Parkinson's disease using [⁶²Cu]ATSM PET.
Nucl Med Biol. 2011; 38(7): 945-951. DOI:10.1016/j.nucmedbio.2011.02.016
Yoshida Y, Kiyono Y, Tsujikawa T, Kurokawa T, Okazawa H, Kotsuji F.
Additional value of 16α-[¹⁸F]fluoro- 17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [¹⁸F]fluorodeoxyglucose PET.
Eur J Nucl Med Mol Img. 2011; 38(10): 1824-1831. DOI: 10.1007/s00259-011-1851-8
Oyama N, Takahara N, Hasegawa Y, Tanase K, Miwa Y, Akino H, Okazawa H, Kudo T, Fujibayashi Y, Yokoyama O.
Assessment of therapeutic effect of sunitinib by ¹¹C-acetate PET compared with FDG PET imaging in a patient with metastatic renal cell carcinoma.
Nucl Med Mol Imaging 2011; 45(3): 217-219. DOI: 10.1007/s13139-011-0084-x
Tsujikawa T, Tsuchida T, Yoshida Y, Kurokawa T, Kiyono Y, Okazawa H, Kimura H.
Role of PET/CT in gynecological tumors based on the Revised FIGO staging classification.
Clin Nucl Med. 2011; 36(9): e114-e118. DOI: 10.1097/RLU.0b013e31821c9a9a
Yoshii Y, Waki A, Yoshida K, Kakezuka A, Kobayashi M, Namiki H, Kuroda Y, Kiyono Y, Yoshii H, Furukawa T, Asai T, Okazawa H, Gelovani JG, Fujibayashi Y.
The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.
Biomaterials. 2011; 32(26): 6052-6058. DOI: 10.1016/j.biomaterials.2011.04.076
Tsuchida T, Demura Y, Sasaki M, Morikawa M, Umeda Y, Tsujikawa T, Kudoh T, Okazawa H, Kimura H.
Differentiation of histological subtypes in lung cancer with ¹⁸F-FDG-PET 3-point imaging and kinetic analysis.
Hell J Nucl Med. 2011; 14(3): 224-227. [http://nuclmed.web.auth.gr/magazine/eng/sept11/14.pdf]
Martinez ME, Kiyono Y, Noriki S, Inai K, Mandap KS, Kobayashi M, Mori T, Tiwari VN, Okazawa H, Welch MJ, Fujibayashi Y, Ido T.
New Radiosynthesis of 2-deoxy-2-[¹⁸F]fluoroacetamido-D-glucopyranose and its evaluation as a bacterial infections imaging agent.
Nucl Med Biol. 2011 ; 38(6): 807-814. DOI: 10.1016/j.nucmedbio.2011.02.006
Tsujikawa T, Tsuchida T, Imamura Y, Kobayashi M, Asahi S, Shimizu K, Tsuji K, Kiyono Y, Okazawa H, Kimura H.
Kikuchi-Fujimoto disease; PET/CT assessment of a rare cause of cervical lymphadenopathy.
Clin Nucl Med. 2011; 36(8): 661-664. DOI: 10.1097/RLU.0b013e31821a2878
Berney A, Leyton M, Gravel P, Sibon I, Sookman D, Rosa-Neto P, Diksic M, Nakai A, Pinard G, Blier P, Todorov C, Okazawa H, Nordahl TE, Benkelfat C.
Brain regional α-[¹¹C]methyl-L-tryptophan trapping in medication-free patients with obsessive compulsive disorder.
Arch Gen Psychiat 2011; 68(7): 732-741. DOI: 10.1001/archgenpsychiatry.2011.16
Isozaki M, Kiyono Y, Arai Y, Kudo T, Mori T, Maruyama R, Kikuta K, Okazawa H.
Feasibility of ⁶²Cu-ATSM PET for evaluation of brain ischemia and misery perfusion in patients with cerebrovascular disease.
Eur J Nucl Med Mol Img. 2011; 38(6): 1075-1082. DOI: 10.1007/s00259-011-1734-z
Ishitobi M, Kosaka H, Omori M, Matsumura Y, Munesue T, Mizukami K, Shimoyama T, Murata T, Sadato N, Okazawa H, Wada Y.
Differential amygdala response to lower face in patients with autistic spectrum disorders: An fMRI study.
Research in Autism Spectrum Disorders 2011, 5(2): 910-919.
Umeda Y, Demura Y, Miwa M, Ameshima S, Tsuchida T, Fujibayashi Y, Okazawa H, Ishizaki T.
Prognostic value of dual-time-point ¹⁸F-FDG PET imaging for patients with pulmonary sarcoidosis.
Respirology 2011; 16(4): 713-720. DOI: 10.1111/j.1440-1843.2011.01966.x
Kobayashi M, Kiyono Y, Maruyama R, Mori T, Kawai K, Okazawa H.
Development of an H₂¹⁵O steady-state method combining a bolus and slow increasing injection with a multi-programming syringe pump.
J Cereb Blood Flow Metab. 2011: 31; 527-534. DOI: 10.1038/jcbfm.2010.122
Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Mori T, Yoshii H, Oh M, Asai T, Okazawa H, Welch MJ, Fujibayashi Y.
Internal radiotherapy with copper-64-diacetyl-bis (N⁴-methylthiosemicarbazone) reduces CD133⁺ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
Nucl Med Biol. 2011 ; 38(2): 151-157. DOI: 10.1016/j.nucmedbio.2010.08.009
Tsujikawa T, Yoshida Y, Kiyono Y, Kurokawa T, Kudo T, Fujibayashi Y, Kotsuji F, Okazawa H.
Functional estrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-estradiol PET.
Eur J Nucl Med Mol Img. 2011; 38(1): 37-45. DOI: 10.1007/s00259-010-1589-8
Arakawa K, Kudo T, Ikawa M, Morikawa N, Kawai Y, Sahashi K, Lee JD, Kuriyama M, Miyamori I, Okazawa H, Yoneda M.
Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion - C-11 acetate kinetics revealed by positron emission tomography-.
Circ J. 2010; 74(12): 2702-2711. DOI: 10.1253/circj.CJ-10-0044
Saito DN, Tanabe HC, Izuma K, Hayashi MJ, Morito Y, Komeda H, Uchiyama H, Kosaka H, Okazawa H, Fujibayashi Y, Sadato N.
"Stay tuned": Inter-individual neural synchronization during mutual gaze and joint attention.
Frontiers in Integrative Neuroscience. 2010; 4(127): 1-12. DOI: 10.3389/fnint.2010.00127
Isozaki M, Arai Y, Kudo T, Kiyono Y, M Kobayashi, Kubota T, Kikuta K, Okazawa H.
Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.
Ann Nucl Med. 2010; 24(5): 371-377. DOI: 10.1007/s12149-010-0367-9
Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Waki A, Mori T, Yoshii H, Oh M, Asai T, Okazawa H, Welch MJ, Fujibayashi Y.
Copper-64-diacetyl-bis (N⁴-methylthiosemicarbazone) accumulates in rich regions of CD133⁺ highly tumorigenic cells in mouse colon carcinoma.
Nucl Med Biol. 2010 May; 37(4): 395-404. DOI: 10.1016/j.nucmedbio.2009.12.011
Kosaka H, Omori M, Munesue T, Ishitobi M, Matsumura Y, Takahashi T, Narita K, Murata T, Saito DN, Uchiyama H, Morita T, Kikuchi M, Mizukami K, Okazawa H, Sadato N, Wada Y.
Smaller insula and inferior frontal volumes in young adults with persive developemental disorders.
Neuroimage. 2010; 50(4): 1357-1363. DOI: 10.1016/j.neuroimage.2010.01.085
Tsujikawa T, Yoneda M, Shimizu Y, Uematsu H, Toyooka M, Ikawa M, Kudo T, Okazawa H, Kuriyama M, Kimura H.
Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images.
Brain Dev. 2010; 32(2): 143-149. DOI: 10.1016/j.braindev.2008.12.003
Kobayashi M, Shikano N, Nishii R, Kiyono Y, Araki H, Nishi K, Oh M, Okudaira H, Ogura M, Yoshimoto M, Okazawa H, Fujibayashi Y, Kawai K.
Comparison of the transcellular transport of FDG and D-glucose by the kidney epithelial cell line, LLC-PK1.
Nucl Med Commun. 2010; 2010, 31(2): 141-146. DOI: 10.1097/MNM.0b013e328333bcf5
Tiwari VN, Kiyono Y, Kobayashi M, Mori T, Kudo T, Okazawa H, Fujibayashi Y.
Automatic labeling method for injectable ¹⁵O-oxygen using hemoglobin-containing liposome vesicles and its application for measurement of brain oxygen consumption by PET.
Nucl Med Biol. 2010; 37(1): 77-83. DOI: 10.1016/j.nucmedbio.2009.08.004
Yoshida Y, Tsujikawa T, Kurokawa T, Tsuji T, Imamura Y, Fujibayashi Y, Okazawa H, Kotsuji F.
Assessment of FDG uptake by leiomyomas in relation to histopathological subtype and the menstrual state.
J Comput Assist Tomogr 2009; 33(6): 877-881. DOI: 10.1097/RCT.0b013e31819f1bb2
Lohith TG, Kudo T, Demura Y, Umeda Y, Kiyono Y, Fujibayashi Y, Okazawa H.
Pathophysiologic correlation between ⁶²Cu-ATSM and ¹⁸F-FDG in lung cancer.
J Nucl Med. 2009; 50(12): 1948-1953. DOI: 10.2967/jnumed.109.069021
Hussain R, Kudo T, Tsujikawa T, Kobayashi M, Fujibayashi Y, Okazawa H.
Validation of the calculation of the clearance rate constant (k_mono) of [¹¹C]acetate using parametric k_mono image for myocardial oxidative metabolism.
Nucl Med Biol. 2009; 36(8): 877-882. DOI: 10.1016/j.nucmedbio.2009.07.002
Kosaka H, Murata T, Takahashi T, Omori M, Okazawa H, Wada Y.
A patient with partial seizures manifested as panic attacks and auditory hallucination.
Epilepsy & Seizure 2009; 2(1): 28-33.
Uchida K, Nakajima H, Miyazaki T, Yayama T, Kawahara H, Kobayashi S, Tsuchida T, Okazawa H, Fujibayashi Y, Baba H.
Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by ¹⁸F-fluoride positron emission tomography: A prospective study.
J Nucl Med. 2009; 50(11): 1804-1814. DOI: 10.2967/jnumed.109.062570
Hussain R, Tsuchida T, Kudo T, Kobayashi M, Tsujikawa T, Kiyono Y, Fujibayashi Y, Okazawa H.
Vasodilatory effect of adenosine triphosphate does not change cerebral blood flow - A PET study with ¹⁵O-water.
Ann Nucl Med. 2009; 23(8): 717-723. DOI: 10.1007/s12149-009-0294-9
Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kobayashi M, Tsuchida T, Fujibayashi Y, Kotsuji F, Okazawa H.
Functional images reflect aggressiveness of endometrial carcinoma: Estrogen receptor expression combined with FDG-PET.
J Nucl Med. 2009; 50(10): 1598-1604. DOI: 10.2967/jnumed.108.060145
Yoshii Y, Furukawa T, Kiyono Y, Mori T, Yoshii H, Kudo T, Okazawa H, Welch MJ, Fujibayashi Y.
Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET.
Nucl Med Biol. 2009; 36(7): 771-777. DOI: 10.1016/j.nucmedbio.2009.05.006
Uchida K, Nakajima H, Yayama T, Kobayashi S, Shimada S, Tsuchida T, Okazawa H, Baba H.
High-resolution magnetic resonance imaging and ¹⁸FDG-PET findings of the cervical spinal cord before and after decompressive surgery in patients with compressive myelopathy.
Spine. 2009; 34(11): 1185-1191.
Yoshida Y, Kurokawa T, Tsujikawa T, Okazawa H, Kotsuji K.
Positron emission tomography in ovarian cancer: ¹⁸F-deoxy-glucose and 16alpha-¹⁸F-fluoro-17beta-estradiol PET.
J Ovarian Research , 2009; 2(1): 7. DOI: 10.1186/1757-2215-2-7
Uchida K, Nakajima H, Takamura T, Kobayashi S, Tsuchida T, Okazawa H, Baba H.
Neurological improvement associated with resolution of irradiation-induced myelopathy: serial magnetic resonance imaging and positron emission tomography findings.
J Neuroimaging. 2009; 19(3): 274-276.
Kudo T, Hata T, Kagawa S, Kishibe Y, Iwasaki J, Okazawa H.
Differences in early-phase tracer distribution in lung between ¹¹C-acetate and ¹³N-ammonia.
Nucl Med Commun. 2009; 30(5): 343-349.
Narita K, Kosaka H, Okazawa H, Murata T, Wada Y.
Relationship between plasma leptin level and brain structure in elderly: A voxel-based morphometric study.
Biol Psychiatry 2009; 65: 992-994.
Umeda Y, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Saito Y, Tsuchida T, Fujibayashi Y, Okazawa H.
Dual-time point ¹⁸F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia.
Eur J Nucl Med Mol Img. 2009; 36: 1121-1130. DOI: 10.1007/s00259-009-1069-1
Yoshii Y, Furukawa T, Yoshii H, Mori T, Kiyono Y, Waki A, Kobayashi M, Tsujikawa T, Kudo T, Okazawa H, Yonekura,Y, Fujibayashi Y.
Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism.
Cancer Sci. 2009; 100: 821-827. DOI: 10.1111/j.1349-7006.2009.01099.x
Okazawa H, Kudo T.
Clinical impact of hemodynamic parameter measurement for cerebrovascular disease using positron emission tomography and ¹⁵O-labeled tracers.
Ann Nucl Med. 2009; 23: 217-227.
Mandap K, Ido T, Kiyono Y, Kobayashi M, Lohith TG, Mori T, Kasamatsu S, Kudo T, Okazawa H, Fujibayashi Y.
Development of microwave-based automated nucleophilic [¹⁸F]fluorination system and its application for the production of [¹⁸F]flumazeni.
Nucl Med Biol. 2009; 36: 403-409.
Ikawa M, Okazawa H, Arakawa K, Kudo T, Kimura H, Fujibayashi Y, Kuriyama M, Yoneda M.
PET imaging of redox and energy states in stroke-like episodes of MELAS.
Mitochondrion, 2009; 9: 144-148.
Demura Y, Tsuchida T, Umeda Y, Uesaka D, Morikawa M, Ameshima S, Ishizaki T, Fujibayashi Y, Okazawa H.
Usefulness of ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic responses in patients with pulmonary mycobacteriosis.
Eur J Nucl Med Mol Imaging 2009; 36: 632-639. DOI: 10.1007/s00259-008-1009-5
Oyama N, Okazawa H, Kusukawa N, Kaneda T, Miwa Y, Akino H, Fujibayashi Y,Yonekura Y, Welch, MJ, Yokoyama O.
¹¹C-acetate PET imaging for renal cell carcinoma.
Eur J Nucl Med Mol Imaging 2009; 36: 422-427.
Fan X, Asai T, Morioka K, Uchida K, Baba H, Tanaka K, Zhuang J, Okazawa H, Fujibayashi Y.
Measurement of glucose metabolism in rat spinal cord slices with dynamic positron autoradiography.
Nucl Med Biol. 2009; 36: 183-189.
Mori T, Suna LQ, Kobayashi M, Kiyono Y, Okazawa H, Furukawa F, Kawashima H, Welch MJ, Fujibayashi Y.
Preparation and evaluation of ethyl [¹⁸F]fluoroacetate as a pro-radiotracer of [¹⁸F]fluoroacetate for the measurement of glial metabolism by PET.
Nucl Med Biol. 2009; 36: 155-162.
Morikawa M, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, Tsuchida T, Kimura H, Fujibayashi Y, Okazawa H.
Effectiveness of ¹⁸F-FDG PET/CT combined with STIR MR for diagnosing nodal involvement in the thorax.
J Nucl Med. 2009; 50: 81-87.
Sun L-Q, Mori T, Kobayashi M, Okazawa H, Furukawa T, Fujibayashi Y.
Automatic synthesis of ethyl [¹⁸F]fluoroacetate and its first PET imaging.
2nd International Conference on Bioinformatics and Biomedical Engineering, iCBBE 2008, art. no. 4535848, pp. 2537-2540.
Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, Fujibayashi Y, Okazawa H.
Evaluation of dual-time point -¹⁸F-FDG PET imaging for staging in patients with lung cancer.
J Nucl Med. 2008; 49: 1606-1612.
Tsujikawa T, Yoshida Y, Mori T, Kurokawa T, Fujibayashi Y, Kotsuji F, Okazawa H.
Uterine tumors: Pathophysiologic imaging with 16α-[¹⁸F]fluoro-17β-estradiol and FDG-PET -Initial experience.
Radiology. 2008; 248: 599-605.
Kudo T, Hata T, Kagawa S, Kishibe Y, Iwasaki J, Nakano A, Okazawa H.
Simple quantification of myocardial perfusion by pixel-by-pixel graphical analysis using carbon-11 acetate: Comparison of the K-complexes of carbon-11 acetate and nitrogen-13 ammonia.
Nucl Med Commun. 2008; 29: 679-685.
Morikawa M, Demura Y, Mizuno S, Ameshima S, Ishizaki T, Okazawa H.
FDG positron emission tomography imaging of drug-induced pneumonitis.
Ann Nucl Med. 2008; 22: 335-338.
Kamibayashi T, Tsuchida T, Demura Y, Tsujikawa T, Okazawa H, Kudoh T, Kimura H.
Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: Influence of attenuation correction method and examination interval.
Mol Imaging Biol. 2008; 10: 162-166.
Kosaka N, Tsuchida T, Uematsu H, Kimura H, Okazawa H, Itoh H.
¹⁸F-fluorodeoxyglucose positron emission tomography in common enhancing malignant brain tumors.
Am J Rentogenol AJR. 2008; 190: W365-W369.
Geshi T, Nakano A, Uzui H, Okazawa H, Yonekura Y, Ueda T, Lee JD.
Relationship between impaired microvascular function in the non-infarct-related area and left-ventricular remodeling in patients with myocardial infarction.
Int J Cardiol. 2008; 126:366-373.
Yoshida Y, Kurokawa T, Sawamura Y, Shinagawa A, Tsujikawa T, Okazawa H, Tsuchida T, Imamura Y, Suganuma N, Kotsuji F.
Comparison of ¹⁸F-FDG-PET and MRI in assessment of uterine smooth muscle tumors.
J Nucl Med. 2008; 49: 708-712.
Tsuchida T, Takeuchi H, Okazawa H, Tsujikawa T, Fujibayashi Y.
Grading of brain glioma with 1-¹¹C-acetate PET: comparison with ¹⁸F-FDG PET.
Nucl Med Biol. 2008; 35: 171-176.
Kobayashi M, Kudo T, Tsujikawa T, Isozaki M, Arai Y, Fujibayashi Y, Okazawa H.
Shorter examination method for the diagnosis of misery perfusion using count-based OEF elevation in ¹⁵O-Gas PET.
J Nucl Med 2008; 49: 242-246.
Tsujikawa T, Okazawa H, Yoshida Y, Mori T, Kobayashi M, Tsuchida T, Fujibayashi Y.
Distinctive FDG and FES accumulation pattern of two tamoxifen-treated patients with endometrial hyperplasia.
Ann Nucl Med. 2008; 22: 73-77.
Tsujikawa T, Otsuka H, Morita N, Saegusa H, Kobayashi M, Okazawa H, Nishitani H.
Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
Ann Nucl Med. 2008; 22: 23-30.
Tsujikawa T, Okazawa H, Tsuchida T, Demura Y, Imamura Y, Fujibayashi Y.
A ¹⁸F-FDG-positive, ⁶⁷Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma.
Ann Nucl Med. 2007; 21: 375-378.
Yoshida Y, Kurokawa T, Sawamura Y, Shinagawa A, Okazawa H, Fujibayashi Y, Kotsuji F.
The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Gynecol Oncol. 2007; 104:764-766.
Tsuchida T, Okazawa H, Mori T, Kobayashi M, Yoshida Y, Fujibayashi Y, Itoh H.
In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET - influence of menstrual cycle and endogenous estrogen level.
Nucl Med Biol. 2007; 34: 205-210.
Okazawa H, Tsuchida T, Kobayashi M, Arai Y, Pagani M, Isozaki M, Yonekura Y.
Can reductions in baseline CBF and vasoreactivity detect misery perfusion in chronic cerebrovascular disease?
Eur J Nucl Med Mol Imaging 2007; 34: 121-129.
Kobayashi M, Okazawa H, Tsuchida T, Kawai K, Fujibayashi Y, Yonekura Y.
Diagnosis of misery perfusion using noninvasive O-15 gas PET.
J Nucl Med 2006; 47: 1581-1586.
Shirasaki H, Nakano A, Uzui H, Yonekura Y, Okazawa H, Ueda T, Lee JD.
Comparative assessment of ¹⁸F-fluorodeoxyglucose PET and ^99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.
Eur J Nucl Med Mol Imaging 2006; 33: 879-886.
Okazawa H, Tsuchida T, Pagani M, Mori T, Kobayashi M, Tanaka F, Yonekura Y.
Effects of 5-HT_1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation.
J Cereb Blood Flow Metab 2006; 26: 92-98.
Kumada T, Okazawa H, Yamauchi H, Kitoh T, Ito M.
Focal glucose hypermetabolism in interictal state of West syndrome.
Pediatr Neurol 2006; 34: 47-50.
Yamauchi H, T Kudoh, K Sugimoto, M Takahashi, Y Kishibe, Okazawa H.
Altered patterns of blood flow response during visual stimulation in carotid artery occlusive disease.
Neuroimage 2005; 25: 554-560.
Okazawa H, Nishizawa S, Tsuchida T, Yonekura Y, Diksic M.
A simplified autoradiographic method with α-[¹⁴C]methyl-tryptophan to measure serotonin synthesis rate in the rat brain.
Nucl Med Biol 2004; 31: 1013-1019.
Yoshida Y, Kurokawa T, Kawahara K, Yagihara A, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F.
Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients.
Gynecol Oncol 2004; 95: 597-602.
Yamauchi H, T Kudoh, K Sugimoto, M Takahashi, Y Kishibe, Okazawa H.
Pattern of collaterals, type of infarcts, and haemodynamic impairment in carotid artery occlusion.
J Neurol Neurosurg Psychiatry 2004; 75: 1697-1701.
Okazawa H, Yamauchi H, Yonekura Y.
Measurement of arterial part of vascular volume (V₀) for the evaluation of hemodynamic changes in cerebrovascular disease.
In: ICS 1265 Quantitation in Biomedical Imaging with PET and MRI, Iida H et al. (ed.), Elsevier, Amsterdam, pp. 218-227, 2004.
Kawahara K, Yoshida Y, Kurokawa T, Suzuki Y, Nagahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F.
Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography.
J Comput Assist Tomogr 2004; 28: 505-516.
Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N, Mzengeza S, Nakai A, Debonnel G, Blier P, Benkelfat C.
Measurement of brain regional α-[¹¹C]methyl-L-tryptophan trapping, as a measure of serotonin synthesis, in medication-free patients with major depression.
Arch Gen Psychiat 2004; 61:556-563.
Okazawa H, Yamauchi H, Sugimoto K, Magata Y, Kudo T, Yonekura Y.
Effects of metabolite correction for arterial input function on quantitative receptor images with ¹¹C-flumazenil in clinical PET studies.
J Comput Assist Tomogr 2004; 28: 428-435.
Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F.
Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
Int J Cancer 2004; 109: 926-932.
Ito H, Kanno I, Kato C, Sasaki T, Ishii K, Ouchi Y, Iida A, Okazawa H, Hayashida K, Tsuyuguchi N, Ishii K, Kuwabara Y, Senda M.
Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with ¹⁵O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan.
Eur J Nucl Med Mol Imaging 2004; 31: 635-643.
Yamauchi H, Okazawa H, Sugimoto K, Kishibe Y, Takahashi M.
The effect of deafferentation on cerebral blood flow response to acetazolamide.
Am J Neuroradiol 2004; 25:92-96.
Yoshida Y, Kurokawa T, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F.
Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer.
Am J Roentgenol 2004; 182: 227-233.
Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M.
Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease.
J Neuro Neurosurg Psychiatry 2004; 75:33-37.
Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y.
Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: A PET study with the acetazolamide test in cerebrovascular disease.
J Nucl Med 2003; 44: 1875-1883.
Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M.
The effect of acetazolamide on the changes of cerebral blood flow and oxygen metabolism during visual stimulation.
Neuroimage 2003; 20:543-549.
Okazawa H, Yamauchi H, Sugimoto K, Takahashi M.
Differences of vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
J Nucl Med 2003; 44:1371-1378.
Fedi M, Reutens DC, Andermann F, Okazawa H, Boling W, White C, Dubeau F, Nakai A, Gross DW, Andermann E, Diksic M.
α-[¹¹C]Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency.
Epilepsy Res 2003; 52: 203-213.
Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M.
Reduced blood flow response to acetazolamide reflects pre-existing vasodilatation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
Eur J Nucl Med 2002; 29:1349-1356.
Okazawa H, Takahashi M, Hata T, Sugimoto K, Kishibe Y, Tsuji T.
Quantitative evaluation of myocardial blood flow and ejection fraction with a single dose of ¹³NH₃ and gated PET.
J Nucl Med 2002; 43: 999-1005.
Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M.
Changes in blood flow and oxygen metabolism during visual stimulation in cerebrovascular disease: Effect of baseline perfusion and oxygen metabolism.
Stroke 2002; 33, 1294-1300.
Okazawa H, Kishibe Y, Sugimoto K, Takahashi M, Yamauchi H.
Delay and dispersion correction for a new coincidential radioactivity detector, Pico-Count, in quantitative PET studies.
In: Brain Imaging Using PET, Senda M et al. (ed.), Academic Press, San Diego, pp.15-21, 2002.
Ito M, Nagafuji H, Okazawa H, Yamakawa K, Sugawara T, Mazaki-Miyazaki E, Hirose S, Fukuma G, Mitsudome A, Wada K, Kaneko S.
Autosomal dominant epilepsy with febrile seizures plus with missense mutations of the (Na⁺)-channel a1 subunit gene, SCN1A.
Epilepsy Res 2002; 48: 15-23.
Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M.
Effects of acetazolamide on cerebral blood flow, blood volume and oxygen metabolism: A PET study with healthy volunteers.
J Cereb Blood Flow Metab 2001; 21: 1472-1479.
Yamane Y, Okazawa H, Blier P, Diksic M.
Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor in the rat brain: An autoradiographic study with α-[¹⁴C]methyl-L-tryptophan.
Biochem Pharmacol 2001; 62; 1481-1489.
Fedi M, Reutens D, Okazawa H, Andermann F, Boling W, Dubeau F, White C, Nakai A, Gross DW, Andermann E, Diksic M.
Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin.
Neurology 2001; 57:1629-1636.
Okazawa H, Yamauchi H, Sugimoto K, Takahashi M, Toyoda H, Kishibe Y, Shio H.
Quantitative comparison of the bolus and steady-state methods for measurement of cerebral perfusion and oxygen metabolism: PET study using ¹⁵O-gas and water.
J Cereb Blood Flow Metab 2001; 21:793-803.
Okazawa H and Vafaee M.
Effect of vascular radioactivity on regional values of cerebral blood flow: evaluation of methods for H₂¹⁵O PET to distinguish cerebral perfusion from blood volume.
J Nucl Med 2001; 42: 1032-1039.
Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S, Young SN, Blier P, Benkelfat C.
Brain regional α-[¹¹C]methyl-L-tryptophan trapping in impressive subjects with borderline personality disorder.
Am J Psychiatry 2001; 158: 775-782.
Okazawa H, Leyton M, Benkelfat C, Mzengeza S, Diksic M.
Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and α-[¹¹C]methyl-L-tryptophan.
J Psychiatry Neurosci 2000; 25: 359-370.
Yamauchi H, Fukuyama H, Nagahama Y, Oyanagi C, Okazawa H, Ueno M, Konishi J, Shio H.
Long-term changes of hemodynamics and metabolism after carotid artery occlusion.
Neurology 2000; 54:2095-2102.
Okazawa H, Yamane F, Blier P, Diksic M.
Effects of acute and chronic administration of the serotonin_1A agonist buspirone on serotonin synthesis in the rat brain.
J Neurochem 1999; 72:2022-31.
Yamauchi H, Fukuyama H, Nagahama Y, Okazawa H, Konishi J.
A decrease in regional cerebral blood volume and hematocrit in crossed cerebellar diaschisis.
Stroke 1999; 30:1429-1431.
Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Okazawa H, Yonekura Y.
Selective cerebral hematocrit decrease in the centrum semiovale after carotid artery occlusion: A PET study.
J Cereb Blood Flow Metab 1999;19:109-114.
Benkelfat C, Young SN, Okazawa H, Leyton M, Diksic M.
The validity of the PET/α-[¹¹C]methyl-L-tryptophan method for measuring rates of serotonin synthesis in the human brain.
Neuropsychopharmacology 1999; 21:153-157.
Okazawa H and Diksic M.
Image generation of serotonin synthesis rates using α-methyltryptophan and PET.
J Comput Assist Tomogr 1998; 22:777-785.
Nishizawa S, Leyton M, Okazawa H, Benkelfat C, Mzengeza S, Diksic M.
Validation of a less-invasive method for measurement of serotonin synthesis rate with α-[¹¹C]methyl-tryptophan.
J Cereb Blood Flow Metab 1998;18:1121-1129.
Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Okazawa H.
Cerebral hematocrit decreases with hemodynamic compromise in carotid artery occlusion: A PET study.
Stroke 1998; 29:98-103.
Hirano S, Naito Y, Okazawa H, Kojima H, Honjo I, Ishizu K, Yenokura Y, Nagahama Y, Fukuyama H, Konishi J.
Cortical activation by monaural speech sound stimulation demonstrated by positron emission tomography.
Exp Brain Res 1997; 113:75-80.
Hirano S, Kojima H, Naito Y, Honjo I, Kamoto Y, Okazawa H, Ishizu K, Yonekura Y, Nagahama Y, Fukuyama H, Konishi J.
Cortical processing mechanism for vocalization with auditory verbal feedback.
Neuroreport 1997;8:2379-2382.
Kojima H, Hirano S, Shoji K, Naito Y, Honjo I, Kamoto Y, Okazawa H, Ishizu K, Yonekura Y, Nagahama Y, Fukuyama H, Konishi J.
The role of the temporal coding system in the auditory cortex on speech recognition.
Neuroreport 1997;8:2395-2398.
Naito Y, Hirano S, Okazawa H, Takahashi H, Ishizu K, Fujiki N, Shiomi Y, Kawano M, Yonekura Y, Honjo I.
Central auditory processing of speech in cochlear implant users demonstrated by positron emission tomography.
Advances in Oto Rhino Laryngology 1997;52:19-23.
Naito Y, Hirano S, Honjo I, Okazawa H, Ishizu K, Takahashi H, Fujiki N, Shiomi Y, Yonekura Y, Konishi J.
Sound-induced activation of auditory cortices in cochlear implant users with post- and prelingual deafness demonstrated by positron emission tomography.
Acta Otolaryngol 1997;117:490-496.
Higuchi Y, Maihara T, Hattori H, Furusho K, Okazawa H, Ishizu K, Yonekura Y.
[F-18]-Fluorodeoxyglucose-positron emission tomography findings in preterm infants with severe periventricular leukomalacia and hypsarrhythmia.
Eur J Pediatrics 1997;156:236-238.
Tanaka F, Yonekura Y, Ikeda A, Terada T, Mikuni N, Nishizawa S, Ishizu K, Okazawa H, Hattori N, Shibasaki H, Konishi J, Onishi Y.
Presurgical identification of epileptic foci with iodine-123 iomazenil SPET: Comparison with brain perfusion SPET and FDG PET.
Eur J Nucl Med 1997;24:27-34.
Hattori N, Yonekura Y, Tanaka F, Fujita T, Wang JY, Ishizu I, Okazawa H, Tamaki N, Konishi J.
One-day protocol for cerebral perfusion reserve with acetazolamide.
J Nucl Med 1996;37:2057-2061.
Onishi Y, Yonekura Y, Tanaka F, Nishizawa S, Okazawa H, Ishizu K, Fujita T, Konishi J, Mukai T.
Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding - the optimal scan time.
Eur J Nucl Med 1996;23:1491-1497.
Ishizu K, Yonekura Y, Magata Y, Okazawa H, Fukuyama H, Tanaka F, Hattori N, Kitano H, Fujita T, Tamaki N, Konishi J.
Extraction and retention of technetium-99m-ECD in human brain: Dynamic spect and oxygen-15-water pet studies.
J Nucl Med 1996;37:1600-1604.
Yonekura Y, Ishizu K, Okazawa H, Tanaka F, Hattori N, Sadato N, Tsuchida T, Nishizawa S, Tamaki N, Nagamine T, Konishi J, Shibasaki H.
Simplified quantification of regional cerebral blood flow with ^99mTc-ECD SPECT and continuous arterial blood sampling.
Ann Nucl Med 1996;10:177-183.
Okazawa H, Naito Y, Yonekura Y, Sadato N, Hirano S, Nishizawa S, Magata Y, Ishizu K, Tamaki N, Honjo I, Konishi J.
Cochlear implant efficiency in pre- and postlingually deaf subjects - A study with H₂¹⁵O and PET.
Brain 1996;119:1297-1306.
Hirano S, Kojima H, Naito Y, Honjo I, Kamoto Y, Okazawa H, Ishizu K, Yonekura Y, Nagahama Y, Fukuyama H, Konishi.
Cortical speech processing mechanisms while vocalizing visually presented languages.
J. Neuroreport 1996;8:363-367.
Okazawa H, Yonekura Y, Fujibayashi Y, Mukai T, Nishizawa S, Magata Y, Ishizu K, Tamaki N, Konishi J.
Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
J Nucl Med 1996;37:1089-1093.
Okazawa H, Yonekura Y, Fujibayashi Y, Yamauchi H, Ishizu K, Nishizawa S, Magata Y, Tamaki N, Fukuyama H, Yokoyama A, Konishi J.
Measurement of regional cerebral plasma pool and hematocrit with copper-62-labeled HSA-DTS.
J Nucl Med 1996; 37: 1080-1085.
Tadamura E, Tamaki N, Okazawa H, Fujibayashi Y, Kudoh T, Yonekura Y, Magata Y, Nohara R, Sasayama S, Konishi J.
Generator-produced copper-62-ptsm as a myocardial pet perfusion tracer compared with nitrogen-13-ammonia.
J Nucl Med 1996;37:729-735.
Onishi Y, Yonekura Y, Nishizawa S, Tanaka F, Okazawa H, Ishizu K, Fujita T, Konishi J, Mukai T.
Noninvasive quantification of iodine-123-iomazenil SPECT.
J Nucl Med 1996; 37: 374-378.
Okazawa H, Yonekura Y, Sadato N, Lyshkow H, Nishizawa S, Asato R, Magata Y, Ishizu K, Tamaki N, Konishi J, Kikuchi H.
Delayed data acquisition for optimal PET activation studies with oxygen-15-water in cerebral arteriovenous malformation.
J Nucl Med 1995;36:2149-2153.
Okazawa H, Fujibayashi Y, Yonekura Y, Tamaki N, Nishizawa S, Magata Y, Ishizu K, Tsuchida T, Sadato N, Konishi J, Yokoyama A, Iwata R, Ido T.
Clinical application of ⁶²Zn/⁶²Cu positron generator: Perfusion and plasma pool images in normal subjects.
Ann Nucl Med 1995;9:81-87.
Taniuchi H, Fujibayashi Y, Okazawa H, Yonekura Y, Konishi J, Yokoyama A.
Cu-pyruvaldehyde-bis(N⁴-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET).
Biol Pharm Bull 1995;18:1126-1129.
Naito Y, Okazawa H, Honjo I, Hirano S, Takahashi H, Shiomi Y, Hoji W, Kawano M, Ishizu K, Yonekura Y.
Cortical activation with sound stimulation in cochlear implant users demonstrated by positron emission tomography.
Cognitive Brain Res 1995;2:207-214.
Naito Y, Okazawa H, Honjo I, Takahashi H, Kawano M, Ishizu K, Yonekura Y.
Cortical activation during sound stimulation in cochlear implant users demonstrated by positron emission tomography.
Annals of Otology, Rhinology, & Laryngology (Supplement) 1995;166:60-64.
Onishi Y, Yonekura Y, Mukai T, Nishizawa S, Tanaka F, Okazawa H, Ishizu K, Fujita T, Sibasaki H, Konishi J.
Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans.
J Nucl Med 1995;36:1201-1210.
Nishizawa S, Yonekura Y, Tanaka F, Fujita T, Tsuchimochi S, Ishizu K, Okazawa H, Tamaki N, Konishi J.
Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine.
J Nucl Med 1995;36:1339-1345.
Tanaka F, Nishizawa S, Yonekura Y, Sadato N, Ishizu K, Okazawa H, Tamaki N, Nakahara I, Taki W, Konishi J.
Changes in cerebral blood flow induced by balloon test occlusion of the internal carotid artery under hypotension.
Eur J Nucl Med 1995;22:1268-1273.
Nagata T, Tanaka F, Yonekura Y, Ikeda A, Nishizawa S, Ishizu K, Okazawa H, Terada K, Mikuni N, Yamamoto I, Shibasaki H, Konishi J, Morita R.
Limited value of interictal brain perfusion SPECT for detection of epileptic foci: High resolution SPECT studies in comparison with FDG-PET.
Ann Nucl Med 1995;9:59-63.
Okazawa H, Yonekura Y, Fujibayashi Y, Nishizawa S, Magata Y, Ishizu K, Tanaka F, Tsuchida T, Tamaki N, Konishi J.
Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
J Nucl Med 1994; 35: 1910-1915.
Sadato N, Yonekura Y, Magata Y, Nishizawa S, Ishizu K, Okazawa H, Tsuchida T, Tanaka F, Tamaki N, Sasayama S, Shibasaki H, Konishi J.
Optimal dose of injection in activation study with O-15 water and PET.
Ann Nucl Med 1994;8:239-243.
Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Miyatake S, Ishikawa M, Kikuchi H, Konishi J.
Effects of hyperglycemia on FDG uptake in human brain and glioma.
J Nucl Med 1994;35:1104-1109.
Ishizu K, Sadato N, Yonekura Y, Nishizawa S, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Tanaka F, Miyatake S, Ishikawa M, Kikuchi H, Konishi J.
Enhanced detection of brain tumors by [¹⁸F]fluorodeoxyglucose PET with glucose loading.
J Comput Assist Tomogr 1994;18:12-15.
Ishizu K, Sadato N, Yonekura Y, Nishizawa S, Magata Y, Tsuchida T, Okazawa H, Tanaka F, Tamaki N, Miyatake S, Ishikawa M, Kikuchi H, Konishi J.
Enhanced detection of brain tumors with glucose loading in FDG-PET studies: quantitative evaluation by fractional uptake.
(In) Quantification of Brain Function: Tracer Kinetics and Image Analysis in Brain PET, Uemura K, Lassen NA, Jones T, Kanno I (eds), Elsevier Science Publishers, Amsterdam, 179-182, 1993.

-Japanese Journal-
Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. (Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association)
The 45th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 48th Survey in 2022)
Kaku Igaku (Jpn J Nucl Med) 2024; 61(1): 1-12. (Open Access) doi: 10.18893/kakuigaku.rp.2431
Okazawa H.
Molecular imaging: Recent studies in neuromolecular imaging.
Innervison 2024; 39(1): 26-29.
Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. (Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association)
The 44th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 47th Survey in 2021)
Kaku Igaku (Jpn J Nucl Med) 2023; 60(1): 1-12. (Open Access) doi: 10.18893/kakuigaku.rp.2331
Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. (Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association)
The 43nd Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 46th Survey in 2020)
Kaku Igaku (Jpn J Nucl Med) 2022; 59(1): 1-12. (Open Access) doi: 10.18893/kakuigaku.rp.2231
Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. (Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association)
The 42nd Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 45th Survey in 2019)
Kaku Igaku (Jpn J Nucl Med) 2021; 58(1): 1-11.(Open Access) doi: 10.18893/kakuigaku.rp.2131
Okazawa H, Ito H, Watanabe Y, Nogami M, Kurihara H, Ito K, Tadokoro M, Kobayashi Y, Sekine T, Kubo H, Yoshikawa K, Sasaki M.
Establishment of standard scan protocol and quantitative evaluation of PET/MRI: A multicenter study. (Report of 2018-2019 WG activity)
Kaku Igaku (Jpn J Nucl Med) 2020; 57(1): 27-29.
Toyama H, Inui Y, Ichihara T, Uno M, Ito K, Kato K, Okazawa H, Ichikawa Y, Yamazaki T.
CT-based attenuation correction and resolution compensation for I-123 IMP brain SPECT normal database: a multicenter phantom study. (Report of 2018-2019 WG activity)
Kaku Igaku (Jpn J Nucl Med) 2020; 57(1): 23-26.
Matsuda H, Uehara T, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 41th report on survey of the adverse reaction to radiopharmaceuticals (The 44th survey in 2018).
Kaku Igaku (Jpn J Nucl Med) 2020; 57(1): 11-21.
Okazawa H.
PET and SPECT studies for hemodynamic evaluation of cerebrovascular diseases.
Igaku-no-Ayumi 2019; 270 (9): 714-719.
Matsuda H, Uehara T, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 40th report on survey of the adverse reaction to radiopharmaceuticals (The 43rd survey in 2017).
Kaku Igaku (Jpn J Nucl Med) 2019; 56(1): 15-23.
Ikawa M, Okazawa H, Yoneda M.
Positron emission tomography imaging for oxidative stress in mitochondrial and neurodegenerative diseases.
Brain Nerve. 2019; 71(2): 161-166. doi: 10.11477/mf.1416201236
Matsuda H, Uehara T, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 39th report on survey of the adverse reaction to radiopharmaceuticals (the 42th survey in 2016).
Kaku Igaku (Jpn J Nucl Med) 2018; 55(1): 51-60.
Matsuda H, Uehara T, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 38th report on survey of the adverse reaction to radiopharmaceuticals (the 41th survey in 2015).
Kaku Igaku (Jpn J Nucl Med) 2017; 53(1): 509-519.
Matsuda H, Arano Y, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 37th report on survey of the adverse reaction to radiopharmaceuticals (the 40th survey in 2014).
Kaku Igaku (Jpn J Nucl Med) 2016; 54(1): 9-20.
Okazawa H, Kosaka H.
Empathy in autistic spectrum disorders. -Comments on Asada and KumagayaЃfs article-.
Jpn Psychol Review 2015; 58(3): 389-391.
Okazawa H.
Basics od dopamine transporter (DAT) imaging and overview of clinical guidelines for DAT-SPECT.
Jpn J Clin Radiol 2015; 60(7): 863-871.
Matsuda H, Arano Y, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 36th report on survey of the adverse reaction to radiopharmaceuticals (the 39th survey in 2013).
Kaku Igaku (Jpn J Nucl Med) 2015; 52(1): 1-12.
Okazawa H.
Quantitative assessment of brain perfusion and metabolism using PET and molecular imaging.
Cereb Blood Flow Metab 2014; 25(2): 85-90.
Okazawa H.
Ioflupane (¹²³I).
J Jpn Med Association 2014; 143(8): 1716-1717.
Tsujikawa T, Maeda H, Okazawa H.
Estrogen receptor imaging for breast cancer by ¹⁸F-FES PET.
Jpn J Breast Cancer 2014; 29(4): 337-342.
Matsuda H, Arano Y, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 35th report on survey of the adverse reaction to radiopharmaceuticals (the 38th survey in 2012).
Kaku Igaku (Jpn J Nucl Med) 2014; 51(1): 1-12.
Tsuyoshi H, Tsujikawa T, Okazawa H, Yoshida Y.
Strategy of malignant tumor treatment: 5 Ovarian cancer
PET Journal 2013; 21: 33-35.
Matsuda H, Arano Y, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M.
The 34th report on survey of the adverse reaction to radiopharmaceuticals (the 37th survey in 2011).
Kaku Igaku (Jpn J Nucl Med) 2013; 50(1): 13-25.
Okazawa H.
Molecular imaging for cerebrovascular disease.
The Mt. Fuji Workshop on CVD 2012; 30: 39-43.
Yoshida Y, Okazawa H.
Differebcial diagnosis of utrine leiomyoma and sarcoma using PET/CT.
Japan Medical Journal 2012; 4590: 65-70.
Matsuda H, Arano Y, Okazawa H, Okamura M, Mizumura S, Yokoyama K.
The 33st report on survey of the adverse reaction to radiopharmaceuticals (the 36th survey in 2010).
Kaku Igaku (Jpn J Nucl Med) 2012; 49(1): 1-14.
Okazawa H, Yoshida Y, Tsujikawa T, Kiyono Y.
Gynecological cancers in the uterus and ovary.
PET Journal 2011; 14: 38-40.
Tsuchida T, Okazawa H.
Quantitative analysis of bone metabolism with F-18 fluoride PET.
Kidney Metab. Bone Dis. 2011; 24: 128-133.
Tsujikawa T, Tsuchida T, Yoshida Y, Kurokawa T, Kiyono Y, Okazawa H, Kimura H.
Role of PET imaging in gynecological tumors.
Jpn J Clin Radiol 2011; 56(6): 730-740.
Matsuda H, Arano Y, Okazawa H, Okamura M, Mizumura S, Yokoyama K.
The 32st report on survey of the adverse reaction to radiopharmaceuticals (the 35th survey in 2009).
Kaku Igaku (Jpn J Nucl Med) 2011; 48(1): 29-41.
Sasaki A, Kosaka H, Nakai A, Namisaki Y, Matsuki K, Sadato N, Okazawa H.
Basic neuroscience on the development of parenthood among adolescent males and females.
Baby Science 2011; 10: 46-59.
Sasaki A, Kosaka H, Suehara K, Machiura M, Sadato N, Okazawa H.
Basic research on the development of parenthood (Part 3): Preparedness for parenthood among adolescent males and females -Continuous learning experience of caring for infants and the evaluation of its effects with the scale of readiness for parenthood and fMRI-.
Jpn J Maternal Health 2010; 51(4): 655-665.
Kimura H, Okazawa H, Arai Y, Kikuta K.
Basic concept and clinical application of continuous arterial spin labeling (CASL) as means of CBF measurement without contrast media: Reliability and limitation.
Jpn J Stroke 2010; 32(6): 675-679.
Okazawa H, Kiyono Y, Tiwari VJ, Mori T, Kobayashi M, Fujibayashi Y.
Measurement of cerebral oxygen metabolism using artificial RBC.
Artificial Blood 2010; 18(3): 97-101.
Okazawa H, Kiyono Y, Isozaki M, Ikawa M, Mori T, Yoneda M.
PET measurement of cerebral blood flow and energy metabolism.
Cerebral Blood Flow and Metabolism 2010; 21(2): 10-14.
Sasaki A, Kosaka H, Suehara K, Machiura M, Namisaki Y, Matsuki K, Sadato N, Okazawa H, Tanabe M.
Basic research on the development of parenthood (Part 2): Comparison of psychological, physiological, and brain activation effects of continuous learning experiences of caring for infants between adolescent males and females.
Jpn J Maternal Health 2010; 51(2): 406-415.
Sasaki A, Kosaka H, Suehara K, Machiura M, Namisaki Y, Matsuki K, Sadato N, Okazawa H, Tanabe M.
Basic research on the development of parenthood (Part 1) -Psychological, physiological, and brain activation effects of continuous learning experiences of caring for infants in adolescent males and females-.
Jpn J Maternal Health 2010; 51(2): 290-330.
Yoshida Y, Kurokawa T, Chino T, Shinagawa A, Kotsuji F, Tsujikawa T, Okazawa H.
The role of PET/CT in gynecological tumors.
Obsterical and Gynecological Therapy 2010; 101(1): 25-33.
Okazawa H, Kiyono Y.
Tumor hypoxic imaging and its clinical application.
Bio Clinica 2010; 25(9): 790-793.
Okazawa H.
Molecular imaging for ischemic cerebrovascular disease using PET.
PET Journal 2010; 10: 36-38.
Saga T, Yoshikawa K, Okazawa H.
Diagnostic PET oncology -PET probes following FDG.
Jpn Med J 2010; 4486: 69-72.
Ito H, Okazawa H.
Nuclear neuroimaging of pathophysiology.
Jpn J Clin Radiol 2010; 55(4): 483-486.
Matsuda H, Arano Y, Okazawa H, Okamura M, Mizumura S, Yokoyama K.
The 31st report on survey of the adverse reaction to radiopharmaceuticals (the 34th survey in 2008).
Kaku Igaku (Jpn J Nucl Med) 2010; 47(1): 29-43.
Kobayashi M, Sugimoto K, Maruyama R, Tsujikawa T, Kudo T, Kiyono Y, Onoguchi M, Kawai K, Fujibayashi Y, Okazawa H.
Effects of transmission scan protocol and attenuation correction method on normal database of 2-[¹⁸F]fluoro-2-deoxy-D-glucose (¹⁸FDG) brain positron emission tomography study.
Jpn J Radiol Technol 2010; 66(1): 42-48. DOI: 10.6009/jjrt.66.42
Okazawa H, Kiyono Y.
Basics of functional imaging.
Jpn J Clin Radiol 2009; 54: 1593-1602.
Kosaka H, Omori M, Munesue T, Ishitobi M, Takahashi T, Murata T, Okazawa H, Sadato N, Wada Y.
Gray matter volume loss in young men with pervasive developemantal disorder revealed by boxel-based morphometry.
Clinical EEG 2009; 51: 483-489.
Okazawa H.
In vivo imaging of oxygen metabolism using PET.
Reference Book of Body and Oxygen 2009; pp136-138.
Okazawa H, Kudo T.
Measurement of cerebral blood flow using H₂¹⁵O PET and its clinical application.
Radioisotope 2009; 58: 209-219.
Okazawa H, Kudo T, Kobayashi M, Kiyono Y, Yoneda M, Fujibayashi Y.
Clinical application of molecular imaging for stroke expression.
Practical Currently 2009; 19: 536-543.
Matsuda H, Arano Y, Okazawa H, Okamura M, Mizumura S, Yokoyama K.
The 30th report on survey of the adverse reaction to radiopharmaceuticals (the 33rd survey in 2007).
Kaku Igaku (Jpn J Nucl Med) 2009; 46: 29-41.
Okazawa H, Kobayashi M, Tsujikawa T, Kudo T, Kiyono Y, Fujibayashi Y, Lohith TG, Tiwari VN.
Feasibility of molecular imaging for cerebrovascular disease and its clinical application.
Jpn J Stroke 2008; 30: 817-821.
Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kurokawa T, Kobayashi M, Tsuchida T, Fujibayashi Y, Okazawa H.
Estrogen receptor expression and glucose metabolism of uterine tumors.
Jpn J Clin Radiol 2008; 53: 1238-1243.
Okazawa H.
Brain function analysis using PET.
PET Journal 2008; 1: 25-27.
Okazawa H.
Hypoxic tissue imaging. [in 5. Molecular imaging of tumors]
Gene & Medicine Mook 9 2008; pp.255-259.
Oyama N, Aoki Y, Tanase K, Matsuda Y, Shioyama R, Nakai M, Miwa Y, Akino H, Yokoyama O, Okazawa H, Fujibayashi Y, Yonekura Y.
¹¹C-Acetate-PET imaging in urological tumor.
Japanese Journal of Clinical Radiology 2006;51:815-822.
Oyama N, Kaneda T, Nakai M, Shioyama R, Matsuda Y, Tanase K, Aoki Y, Miwa Y, Akino H, Yokoyama O, Okazawa H, Fujibayashi Y, Yonekura Y.
PET imaging in prostate cancer.
Hinyokika Kiyo 2006;52:503-505.
Okazawa H.
Relationship between misery perfusion and vasodilatory capacity assessed by acetazolamide test in patients with cerebrovascular disease.
Jpn J Stroke 2005; 27: 643-647.
Okazawa H.
Cerebrovascular disease.
Medcine and Drug Journal 2005;41:2575-2580.
Yoshida H, Fukuimura Y, Suzuki S, Okazawa H.
Application of FDG-PET for clinical follow-up in postoperative cases of oropharyngeal cancers.
Dental Diamond 2005; 60:66-71.
Okazawa H, Ito M, Sugimoto K, Fedi M, Diksic M, Yonekura Y.
Diagnosis of epileptic foci using PET: Comparison of images for glucose metabolism, amino acid consumption and receptor density.
Ann Rep Jpn Epi Res Found 2004; 16: 19-28.
Okazawa H.
Measurement of cerebral blood flow with positron emission tomography (PET).
Medcine and Drug Journal 2004;40:1445-1450.
Senda M, Ouchi Y, Ishii K, Ishii K, Ikeda S, Nasu S, Kawabe J, Ishizu K, Kato N, Kuwabara Y, Ito K, Hayashida K, Okazawa H, Uno K, Nakashima T, Oku N, Torizuka K.
A Japanese nationwide survey on the FDG-PET scans for dementia: Analysis on the predicted costs and benefits of FDG-PET for early diagnosis of Alzheimer.
Radioisotopes 2003;52:585-598.
Yonekura Y, Ishida Y, Magata Y, Miyake Y, Hayashida K, Ishizu K, Okazawa H, Kudo T, Higashi T, Tamaki N, Kasagi K, Konishi J.
Clinical value of positron emission tomography (PET) using automated production system of oxygen-15 water.
Radioisotopes 1996;45:689-695.
Hirano S, Kojima H, Naito Y, Honjo I, Kamoto Y, Okazawa H, Ishizu K, Yonekura Y.
Brain activity in the motor speech areas and the auditory areas during vocalization, as demonstrated by positron emission tomography.
Jibi Rinsho 1996;89:1401-1406.
Onishi Y, Yonekura Y, Tanaka F, Nishizawa S, Okazawa H, Ishizu K, Fujita T, Konishi J, Mukai T.
Parametric images of central-type benzodiazepine receptor binding and ligand transport by two SPECT scans of 123I-iomazenil: relative quantification without blood data.
Kaku Igaku (Jpn J Nucl Med) 1996;33:953-963.
Yonekura Y, Fukuyama H, Pagani M, Ishizu K, Okazawa H, Nishizawa S, Fujibayashi Y.
Effects of occlusive carotid lesions on cerebral blood flow and metabolism: Retrospective analysis of PET measurement.
Myakkangaku 1995;35:375-379.
Yonekura Y, Nishizawa S, Tanaka F, Ishizu K, Okazawa H, Fujita T, Konishi J, Torizuka K.
Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT.
Kaku Igaku (Jpn J Nucl Med) 1995;32:87-97.
Naito Y, Okazawa H, Honjo I, Takahashi H, Shiomi Y, Ishizu K, Nishizawa S, Yonekura Y.
Speech recognition in cochlear implant users.
Jibi Rinsho 1994;87:1622-3.
Tamaki N, Tadamura E, Kawamoto M, Torizuka T, Inokuma T, Okazawa H, Tanaka F, Nishizawa S, Ishizu K, Magata Y, Yonekura Y, Konishi J.
Positron emission tomography for assessing patients with coronary artery disease.
Japanese Journal of Clinical Radiology 1993;38:1673-1681.
Okazawa H, Endo K, Saga T, Watanabe Y, Nakai T, Kasagi K, Konishi J, Abe M, Goto K, Nakao K, Murakami T, Matsunaga M, Kawai C.
Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case.
Nippon Igaku Hoshasen Gakkai Zasshi (Journal of Japan Radiological Society) 1990;50:286-294.

Presentation

Okazawa H.
Neuromolecular imaging: History and new waves.
2023 Annual Conference of Society of Nuclear Medicine, Taiwan (TSNM2023), 2023, 11.12 (Taichung).
Okazawa H, Ikawa M, Mori T, Makino A, Nogami M, Kiyono Y, Kosaka H.
Increased oxidative stress in the brain of early AlzheimerЃfs disease.
The 70th Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging (SNMMI 2023), 2023, 6.24-27 (Chicago).
Okazawa H, Ikawa M, Mori T, Makino A, Nogami M, Kiyono Y, Kosaka H.
Differences in cerebral oxidative stress between early AlzheimerЃfs disease and healthy controls analyzed using multimodality images from PET/MRI.
Brain & Brain PET 2023 (XXXIst International Symposium on Cerebral Blood Flow, Metabolism and Function & The 16th International Conference on Quantification of Brain Function with PET), 2023, 6.12-14 (Brisbane)
Okazawa H.
Overview and frontiers of nuclear neurology.
WFNMB 2022 Post-congress Symposium, 2022.9.12 (Kanazawa).
Okazawa H, Ikawa M, Tsujikawa T, Mori T, Makino A, Kiyono Y, Kosaka H.
Comparison of oxidative stress in the brain of AlzheimerЃfs disease and healthy controls.
WFNMB 2022; 2022.9.7-11 Hybrid meeting (Kyoto).
Okazawa H, Ikawa M, Tsujikawa T, Mori T, Makino A, Kiyono Y, Kosaka H.
Regional changes in cerebral oxidative stress in early AlzheimerЃfs disease.
Brain/Brain PET 2022; 2022.5.28-6.1 Hybrid meeting (Glasgow).
Okazawa H, Ikawa M, Minyoung J, Tsujikawa T, Mori T, Makino A, Kiyono Y, Kosaka H.
Evaluation of functional changes in AlzheimerЃfs disease using multimodal PiB-PET/MRI.
NeuroReceptor Mapping 2021 Web meeting (Montreal).
Okazawa H.
Imaging Oxidative Stress in Neurodegenerative Diseases. In the Joint Symposium 26 (EANM/ESMI/WMIS): Imaging Mitochondria and Mitochondrial Dysfunction
The 34th Annual Congress of the European Association of Nuclear Medicine (EANM2021) Virtual, 2021, 10.20-23, Web meeting (Virtual).
Okazawa H.
Current PET/MRI technique for quantitative evaluation of brain imaging.
The 18th Asian Oceanian Congress of Radiology (AOCR 2021), 2021, 4.14-16, Yokohama (Japan).
Okazawa H, Islam MM, Rahman MGM, Tsujikawa T.
Development of an automatic calculation method for the specific binding ratio in [I-123]ioflupne SPECT.
The 33rd Annual Congress of the European Association of Nuclear Medicine (EANM2020), 2020, 10.22-30, Web meeting (Austria).
Okazawa H, Ikawa M, Jung M, Tsujikawa T, Mori T, Makino M, Kiyono Y, Kosaka H.
Multimodal evaluation of brain functions in patients with AlzheimerЃfs disease using PiB-PET/MRI.
The 67th Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging (SNMMI 2020), 2020, 7.11-14, Web meeting (USA).
Okazawa H.
PET/MR International Experience and Opportunities -PET/MR in Japan-.
2020 Annual Meeting of American College of Nuclear Medicine (ACNM), 2020.01.24, Tampa (USA).
Okazawa H.
Quantitative brain PET/MRI imaging and its clinical application.
Brain & Brain PET 2019 (XXIXth International Symposium on Cerebral Blood Flow, Metabolism and Function & The 14th International Conference on Quantification of Brain Function with PET), 2019, 7.4-7 (7.6), Yokohama (Japan).
Kiyono Y, Mori T, Asai T, Okazawa H.
Evaluation of radiobromine-labeled (SS)-BPBM for imaging of the brain norepinephrine transporter.
Brain & Brain PET 2019 (XXIXth International Symposium on Cerebral Blood Flow, Metabolism and Function & The 14th International Conference on Quantification of Brain Function with PET), 2019, 7.4-7 (7.5), Yokohama (Japan).
Okazawa H, Tsujikawa T, Higashino Y, Mori T, Makino M, Kiyono Y.
Comparison of MR attenuation correction methods using CT-atlas vs. zero-TE on quantitative H₂¹⁵O-PET/MRI.
Brain & Brain PET 2019 (XXIXth International Symposium on Cerebral Blood Flow, Metabolism and Function & The 14th International Conference on Quantification of Brain Function with PET), 2019, 7.4-7 (7.4), Yokohama (Japan).
Tsujikawa T, Tsuyoshi H, Yamada S, Shinagawa A, Chino Y, Kurokawa T, Yoshida Y, Okazawa H.
¹⁸F-FDG PET/MRI with high-resolution DWI characterizes the distinct phenotypes of endometrial cancer.
The 66th Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2019, 6.22-25 (6.22), Denver (USA).
Okazawa H, Tsujikawa T, Higashino Y, Mori T, Makino M, Kiyono Y.
Comparison of MR attenuation correction using CT-atlas based vs. zero-TE on quantitative ¹⁵O-water PET/MRI.
The 66th Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2019, 6.22-25 (6.22), Denver (USA).
Okazawa H, Ikawa M, Tsujikawa T, Kosaka H.
Brain PET/MRI for evaluation of neurodegenerative diseases.
The 13th Asia Oceania Congress of Nuclear Medicine and Biology, 2019, 5. Shanghai (China).
Rahman M, Islam M, Tsujikawa T, Kiyono Y, Okazawa H.
A new method for [¹²³I]FP-CIT specific binding ratio estimation in evaluation of striatal function.
The 65th Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2018, 6, Philadelphia(USA).
Rahman M, Islam M, Tsujikawa T, Sugimoto K, Okazawa H.
Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
The 12th World Congress of the World Federation of Nuclear Medicine and Biology (WFNMB 2018), 2018, 4, Melbourne (Australia).
Okazawa H, Higashino Y, Tsujikawa T, Mori T, Arishima H, Kiyono Y, Kikuta K.
Measurement of cerebral blood flow using H₂¹⁵O PET/MRI with a noninvasive method.
The 64th Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2017, 6, Denver (USA).
Okazawa H, Tsujikawa T, Higashino Y, Arishima H, Mori T, Kiyono Y, Kikuta K.
Measurement of cerebral blood flow with H₂¹⁵O PET/MRI.
Brain/Brain PET 2017; International Symposium on Cerebral Blood Flow, Metabolism and Function, 2017, 4, Berlin (Germany).
Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H.
Clinical benefits of precise delay correction for CBF measurement in O-15 water PET study.
The 63rd Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2016, 6, San Diego (USA).
Okazawa H, Ikawa M, Yoneda M.
Imaging oxidative stress in the brain.
The 6th International Society of Radiation Neurobiology Conference (ISNR-2016), 2016. 2, Nagasaki, Japan.
Okazawa H, Ikawa M, Tsujikawa T, Mori T, Makino A, Kiyono Y, Yoneda M.
Evaluation of nigrostriatal oxidative stress intensity in patients with ParkinsonЃfs disease using [Cu-62]ATSM PET and FP-CIT SPECT.
Annual Congress of the European Association of Nuclear Medicine (EANM2015), 2015, 10, Hamburg (Germany)
Okazawa H, Ikawa M, Tsujikawa T, Mori T, Kiyono Y, Yoneda M.
Evaluation of Striatal oxidative stress in ParkinsonЃfs disease using [Cu-62]ATSM PET.
Brain & Brain PET 2015; XXVIIth International Symposium on Cerebral Blood Flow, Metabolism and Function, 2015, 6, Vancouver (Canada).
Tsujikawa T, Asahi S, Oh M, Mori T, Kiyono Y, Okazawa H.
Prediction of head and neck cancer outcome evaluated by tumor redox status using ⁶²Cu-ATSM PET.
The 62nd Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2015, 6, Baltimore (USA).
Okazawa H.
Imaging Oxidative Stress.
4th European Conference on Clinical Neuroimaging (ECCN2015), 2015, 3, Rome (Italy).
IsozakiM, Tada A, Tsujikawa T, Kimura H, Kikuta K, Okazawa H.
Feasibility of pulsed continuous arterial spin labeling (pCASL) in quantitative evaluation of cerebral blood flow: Comparison with quantitative SPECT and PET.
Annual Congress of the European Association of Nuclear Medicine (EANM2014) , 2014, 10, Goyhenburg (Sweden).
Okazawa H, Tsujikawa T, Sato Y, Mori T, Fujieda S, Kiyono Y.
Hypoxic volume measurement using Cu-ATSM PET may be a predictive index for prognosis of advanced head-and-neck cancers: Comparison with FDG-PET.
2014 World Molecular Imaging Congress 2014, 9, Seoul (Korea).
Okazawa H, Ikawa M, Tsujikawa T, Matsunaga A, Mori T, Kiyono Y, Yoneda M.
Evaluation of cerebral oxidative stress in amyotrophic lateral sclerosis using ⁶²Cu-ATSM PET.
The 61st Annual Meeting of The Society of Nuclear Medicine and Molecular Imaging, 2014, 6, St. Louis (USA). J Nucl Med 2014; 55(Suppl.1): 435P (SNM Abstract No.1831)
Sato Y, Oh M, Kimura Y, Kiyono Y, Mori T, Fujieda S, Okazawa H.
Cu-ATSM uptake may predict prognosis after treatment in advanced head-and-neck cancers: Evaluation of resistant hypoxic tissue with tumor-to-muscle ratio.
RSNA 2013, 2013.12, Chicago (USA), (Abstract No. VSNM21-12)
Saito DN, Yanaka H, Kochiyama T, Fujii T, Kosaka H, Muramatsu T, Shimada T, Matsumura K, Sato M, Okazawa H.
The development of attentional network during childhood and adult: an fMRI study.
19th Annual Meeting of The Organization for Human Brain Mapping , 2013, 6, Seattle (USA).(Abstract No. 3740)
Sato Y, Oh M, Kimura Y, Kiyono Y, Mori T, Fujieda S, Okazawa H.
Tumor-to-muscle ratio of Cu-ATSM uptake may reflect outcome of treatment in head-and-neck cancers: Predictability of resistant hypoxic tissue.
The 60th Annual Meeting of The Society of Nuclear Medicine, 2013, 6, Vancouver (Canada). J Nucl Med 2013; 54(Suppl.2): 348P (SNM Abstract No.1524)
Fujii T, Saito D, Yanaka H, Kosaka H, Okazawa H.
Depressive mood modulates anterior lateral CA1 during a pattern separation task in healthy individuals: a functional MRI study.
Brain2013: XXVIth International Symposium on Cerebral Blood Flow, Metabolism and Function, 2013, 5, Shanghai (China).
Asai T, Fukumoto S, Wang W, Okazawa H.
Effect of nonsteroidal anti-inflammatory drug celecoxib on cerebral glucose metabolism in rat brain slices as measured by dynamic positron autoradiography.
Brain2013: XXVIth International Symposium on Cerebral Blood Flow, Metabolism and Function, 2013, 5, Shanghai (China).
Okazawa H, Kimura Y, Oh M, Kiyono Y, Mori T, Fujieda S.
Relationship between effects of treatment and Cu-ATSM uptake in head-and-neck cancers: Predictability of resistant hypoxic tissue in cancers.
Annual Congress of the European Association of Nuclear Medicine (EANM2012) , 2012, 10, Milan (Italy). Eur J Nucl Med Mol Imaging. 2012; 39(Suppl.2): S383 (PW116).
Okazawa H, Kimura Y, Oh M, Kiyono Y, Mori T, Fujieda S.
Predictability of treatment effects with Cu-ATSM PET in head-and-neck cancers: Comparison with FDG-PET.
2012 World Molecular Imaging Congress 2012, 9, Dublin (Ireland).
Okazawa H, Kimura Y, Kiyono Y, Mori T, Fujieda S.
Predictability of ⁶²Cu-ATSM uptake to evaluate resistant hypoxic tissue and effects of treatment in head-and-neck cancers.
The 59th Annual Meeting of The Society of Nuclear Medicine, 2012, 6, Miami Beach (USA). J Nucl Med 2012; 53(Suppl.1): 281P (SNM Abstract No.1342)
Okazawa H.
Cerebrovascular Disease and O-15 PET.
International Symposium on Flow Measurement in Cerebrovascular Disease -Management of Hemodynamic Stroke-, 2011, 11, Seoul (Korea).
Okazawa H, Kositwattanarerk A, Kimura Y, Kiyono Y, Mori T, Fujieda S.
Predictive value of tracer accumulation to evaluate effects of cancer treatment studied using ⁶²Cu-ATSM and ¹⁸F-FDG PET in head-and-neck cancers.
Annual Congress of the European Association of Nuclear Medicine (EANM2011) , 2011, 10, Birmingham (UK). Eur J Nucl Med Mol Imaging. 2011; 38(Suppl.2): S344 (P349).
Yoshida Y, Kiyono Y, Tsujikawa T, Kurokawa T, Mori T, Okazawa H.
Additional diagnostic value of [F-18]fluoroestradiol PET in patients with uterine smooth muscle tumors.
The 58th Annual Meeting of The Society of Nuclear Medicine, 2011, 6, San Antonio (USA). J Nucl Med 2011; 52(Suppl.1): 414P (SNM Abstract No.1847)
Okazawa H, Isozaki M, Kudo T, Arai Y, Kiyono Y.
Evaluation of brain ischemic regions in patients with cerebrovascular disease using PET and hypoxic imaging tracer ⁶²Cu-ATSM.
RSNA2010, 2010, 11, Chicago (USA).
Okazawa H, Isozaki M, Arai Y, Kiyono Y, Kudo T, Mori T, Kikuta K.
Feasibility of ⁶²Cu-ATSM PET to delineate misery perfusion in patients with major cerebral arterial occlusive disease.
Annual Congress of the European Association of Nuclear Medicine (EANM2010) , 2010, 10, Vienna. Eur J Nucl Med Mol Imaging. 2010; 37(Suppl.2): S218 (OP125).
Okazawa H, Oh M, Kudo T, Kiyono Y, Kobayashi M, Mori T, Fujibayashi Y.
Different distribution of ⁶²Cu-ATSM and ¹⁸F-FDG in head-and-neck cancers.
The 57th Annual Meeting of The Society of Nuclear Medicine, 2010, 6, Salt Lake City. J Nucl Med 2010; 51: 20P (SNM Abstract No.73)
Oh M, Kudo T, Kiyono Y, Maruyama R, Fujibayashi Y, Okazawa H.
Does different distribution of ⁶²Cu-ATSM and ¹⁸F-FDG reflect resistant tissue of cancers?
2009 World Molecular Imaging Congress 2009, 9, Montreal (Canada).
Okazawa H, Kudo T, Kobayashi M, Isozaki M, Arai Y, Tsujikawa T, Fujibayashi Y, Kubota T.
Benefit of pixel-by-pixel delay correction for measurement of hemodynamic parameters in patients with cerebrovascular disease using O-15 PET.
Brain PET 09 (9th International Conference on Quantification of Brain Function with PET), 2009, June, Chicago (U.S.A.).
Okazawa H.
Clinical PET imaging using Cu-62-ATSM. SNM Continuing Education Session "Hypoxic Imaging: Nitroimidazole vs. Cu-ATSM"
The 55th Annual Meeting of the Society of Nuclear Medicine 2008, 6, New Orleans (USA).
Okazawa H.
Clinical Application of Molecular Imaging.
The 12th Conference of Peace through Mind/Brain Science 2008.2, Hamamatsu.
Okazawa H, Tsujikawa T, Kobayashi M, Isozaki M, Arai Y.
Accurate delay correction for quantitative measurement of cerebral blood flow and arterial-to-capillary blood volume (V₀).
The 8th International Conference on Quantification of Brain Function with PET 2007, May, Osaka.
Okazawa H, Tsujikawa T, Arai Y, Kobayashi M, Isozaki M, Fujibayashi Y.
Importance of baseline CBF evaluation for detection of critical hemodynamic status in cerebrovascular disease: Comparison with acetazolamide test using PET.
The 23rd International Symposium on Cerebral Blood Flow, Metabolism and Function 2007, May, Osaka.
Okazawa H, Yoshida Y, Tsujikawa T, Mori T, Tsuchida T, Kobayashi M, Fujibayashi Y.
Evaluation of gynecological tumors and endometriosis using F-18 fluoroestradiol and PET.
World Journal of Nuclear Medicine 2006; 5: S184 (WCNMB Abstract No. 3492), Seoul.
Okazawa H, Tsuchida T, Arai Y, Kobayashi M, Mori T, Tsujikawa T, Yonekura Y, Fujibayashi Y.
How accurately can reductions in baseline CBF and vasoreactivity detect misery perfusion in cerebrovascular disease?
Eur J Nucl Med Mol Imaging 2006; 33: S297 (EANM Abstract No. P356), Athens.
Okazawa H, Yoshida Y, Mori T, Tsuchida T, Kurokawa T, Kobayashi M, Tsujikawa T, Yonekura Y, Fujibayashi Y.
Evaluation of gynecological tumors and endometriosis using [F-18]-fluoroestradiol and PET.
Eur J Nucl Med Mol Imaging 2006; 33: S264 (EANM Abstract No. P188), Athens.
Okazawa H, Yoshida Y, Mori T, Tsuchida T, Kurokawa T, Kobayashi M, Fujibayashi Y, Yonekura Y.
Evaluation of Uterine Endometrium Related Gynecological Diseases using F-18 Fluoroestradiol and PET.
The 53rd Annual Meeting of The Society of Nuclear Medicine, 2006, 6, San Diego. J Nucl Med 2006; 47: 318P (SNM Abstract No.1265)
Okazawa H.
PET and univariate analysis. In Symposium: The clinical impact of statistical methods in the assessment of brain diseases with PET and SPECT. Annual Congress of the European Assocation of Nuclear Medicine 2005
Eur J Nucl Med Mol Imaging 2005; 32: S27 (EANM Abstract No. 40c), October, Istanbul.
Okazawa H, Tsuchida T, Arai Y, Mori T, Kobayashi M, Tanaka F, Fujibayashi Y, Yonekura Y.
Relationship between misery perfusion and vasodilatory capacity assessed by acetazolamide test in patients with cerebrovascular disease: A PET study with O-15 gas and water.
The 52rd Annual Meeting of The Society of Nuclear Medicine 2005, 6, Toronto. J Nucl Med 2005; 46: 303P (SNM Abstract No.992)
Okazawa H, Tsuchida T, Pagani M, Mori T, Tanaka F, Kobayashi M, Yonekura Y.
Effects of 5-HT_1B/1D receptor agonist on cerebral blood flow and arterial blood volume: PET study with healthy volunteers.
Human Brain Mapping 2005, 2005, 6, Toronto.
Okazawa H, Tsuchida T, Arai Y, Mori T, Kobayashi M, Tanaka F, Yonekura Y.
Evaluation of critical hemodynamic status induced by acetazolamide challenge in patients with cerebrovascular disease: Assessment of regional perfusion pressure.
XXIInd International Symposium on Cerebral Blood Flow, Metabolism, and Function & VIIth International Conference on Quantification of Brain Function with PET 2005, 6, Amsterdam.
Okazawa H, Tsuchida T, Mori T, Fujibayashi Y, Yonekura Y.
Evaluation of critical changes in cerebral perfusion pressure induced by vasodilatory stimulus in patients with cerebrovascular disease.
Fukui 2004 (The 3rd International Workshop on Biomedical Imaging) 2004, 12, Fukui, Japan.
Okazawa H, Tsuchida T, Yamauchi H, Yonekura Y.
PET measurement of arterial part of cerebral perfusion pressure for evaluation of hemodynamic changes in cerebrovascular disease.
Eur J Nucl Med Mol Imaging 2004; 31: S366 (EANM Abstract No. P351).
Okazawa H, Yamauchi H, Sugimoto K, Kudo T, Takahashi M, Kishibe Y, Yonekura Y.
Effects of metabolite correction for arterial input function and different calculation methods on quantitative receptor images in ¹¹C-flumazenil PET study.
Eur J Nucl Med Mol Imaging 2004; 31: S376 (EANM Abstract No. P401).
Okazawa H, Yamauchi H, Tsuchida T, Takahashi M, Fujibayashi Y, Yonekura Y.
Effects of acetazolamide on cerebral perfusion pressure in patients with cerebrovascular disease.
J Nucl Med 2004; 45:268P (SNM Abstract No.858).
Okazawa H, Yamauchi H, Yonekura Y.
Measurement of arterial part of vascular volume (V₀) for evaluation of hemodynamic changes in cerebrovascular disease.
International Workshop on Quantitation in Biomedical Imaging with PET and MRI, 2004,1, Osaka.
Okazawa H, Yamauchi H, Takahashi M, Kishibe Y, Matsugi H, Sugimoto K.
Changes in cerebral blood flow and blood volume induced by acetazolamide challenge studied in patients with moyamoya disease: A PET study using the H₂¹⁵O bolus method.
J Cereb Blood Flow Metab 2003; 23:S605 (Brain 03/Brain PET03 Abstract).
Okazawa H, Yamauchi H, Takahashi M, Kishibe Y, Sugimoto K.
Relationship of vasodilatation and cerebral blood flow increase induced by acetazolamide studied in patients with cerebrovascular disease.
J Nucl Med 2003; 44: 239P (SNM Abstract No.866).
Okazawa H, Yamauchi H, Sugimoto K, Kishibe Y, Takahashi M.
Changes in cerebral blood flow and blood volume after acetazolamide challenge studied with PET.
J Nucl Med 2002; 43: 147P (SNM Abstract No.535).
Okazawa H, Takahashi M, Hata T, Sugimoto K, Kishibe Y, Tsuji T.
Simultaneous measurement of myocardial blood flow and ejection fraction with a single dose of ¹³NH₃.
J Nucl Med 2002; 43: 187P (SNM Abstract No.771).
Okazawa H, Yamauchi H, Sugimoto K, Takahashi M, Kishibe Y.
Effects of acetazolamide on cerebral blood flow and blood volume in PET studies with healthy volunteers.
J Cereb Blood Flow Metab 2001; 21:S145 (Brain 01/Brain PET01 Abstract).
Okazawa H, Kishibe Y, Sugimoto K, Takahashi M, Yamauchi Y.
Delay and dispersion correction for a new coincidential radioactivity detector, Pico-Count, in quantitative PET studies.
J Cereb Blood Flow Metab 2001; 21:S553 (Brain 01/Brain PET01 Abstract).
Okazawa H, Yamauchi H, Sugimoto K, Kishibe Y, Takahashi M.
A new simplified method for measurement of cerebral physiological parameters in PET: normal values and application to patients.
J Nucl Med 2001; 42: 221P (SNM Abstract No.941).
Okazawa H, Takahashi M, Hata T, Sugimoto K, Kishibe Y.
Measurement of myocardial blood flow and ejection fraction with a single dose of ¹³NH₃ and PET: evaluation of gated PET.
J Nucl Med 2001; 42: 166P (SNM Abstract No.721).
Okazawa H and Vafaee M.
Effects of vascular radioactivities on regional values of cerebral blood flow in H₂¹⁵O PET.
J Nucl Med 2000; 41: 62P (SNM Abstract No.242).
Okazawa H, Yamauchi H, Sugimoto K, Takahashi M, Kishibe Y, Shio H.
Evaluation of cerebral metabolic rate and extraction fraction of oxygen in ¹⁵O₂ bolus inhalation method coupled with H₂¹⁵O PET.
J Nucl Med 2000; 41: 214P (SNM Abstract No.957).
Okazawa H, Yamane F, Blier P, Diksic M.
Effects of the 5-HT_1A agonist buspirone on serotonin synthesis in the rat brain: Acute and chronic treatment study.
J Cereb Blood Flow Metab 1999; 19:S320 (Brain 99/Brain PET99 Abstract).
Okazawa H, Leyton M, Diksic M, Sookman D, Blier P, Paris J, Benkelfat C.
Regional rates of brain serotonin synthesis in patients with borderline personality disorder vs obsessive-compulsive disorder: Analysis with statistical parametric mapping.
NeuroImage 1998; 7: S233 (HBM98 Abstract).
Okazawa H and Diksic M.
Differences of regional serotonin synthesis rates in healthy controls with statistical parametrical mapping and serotonin synthesis rate images.
J Nucl Med 1998; 39: 136P (SNM Abstract).
Okazawa H, Benkelfat C, Leyton M and Diksic M.
Comparison of serotonin synthesis rates in normal controls and psychiatric disorders using serotonin synthesis rate images.
J Nucl Med 1998; 39: 83P (SNM Abstract).
Okazawa H, Nishizawa S and Diksic M.
Serotonin synthesis rate images using alpha-methyl-tryptophan and PET.
J Nucl Med 1997; 38: 195P (SNM Abstract).
Okazawa H, Naito N, Hirano S, et al.
Auditory activation studies to the patients with cochlear implantation and hearing subjects.
J Nucl Med 1996; 37: 123P (SNM Abstract).
Okazawa H, Yonekura Y, Fujibayashi Y, Mukai T, Nishizawa S, Magata Y, Ishizu K, Tanaka F, Tamaki N, Konishi J.
Estimation of regional cerebral blood flow with copper-62 PTSM and 3-compartment model.
J Nucl Med 1995; 36: 128P (SNM Abstract).
Okazawa H, Yonekura Y, Fujibayashi Y, Nishizawa S, Magata Y, Tamaki N, Ishizu K, Ouchi Y, Yamauchi H, Konishi J.
PET measurement of regional cerebral plasma volume and hematocrit using copper-62 labeled HSA.
J Nucl Med 1995; 36: 239P (SNM Abstract).
Okazawa H, Naito N, Yonekura Y, et al.
Auditory activation studies to the patients with cochlear implantation.
J Cereb Blood Flow Metab 1995; 15:S833 (Brain 95 Abstract).
Okazawa H, Yonekura Y, Fujibayashi Y, et al.
Measurement of regional cerebral hematocrit in cerebrovascular disease using copper-62 labeled HSA.
J Cereb Blood Flow Metab 1995; 15:S683 (Brain 95 Abstract).
Okazawa H, Naito N, Yonekura Y, et al.
Evaluation of cochlear implant efficiency in the deaf patients using positron emission tomography and O-15 water.
J Nucl Med 1994; 35: 95P (SMN Abstract).
Okazawa H, Yonekura Y, Fujibayashi Y, et al.
Quantitative evaluation of generator-produced copper-62 PTSM as a brain perfusion tracer for PET.
J Nucl Med 1994; 35: 201P (SNM Abstract).
Okazawa H, Sadato N, Yonekura Y, et al.
PET activation studies with MRI in cerebral arteriovenous malformation.
J Cereb Blood Flow Metab 1993; 13: S341 (Brain 93 Abstract).

[Back][Home][BIC People][BIRC][Others]

Publication

-Japanese Journal-

Presentation